| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 9.16e-16 | 114 | 268 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 4.60e-15 | 124 | 268 | 19 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 3.02e-14 | 137 | 268 | 19 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.41e-11 | 192 | 268 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | histone modifying activity | SRCAP JARID2 KMT2A MEAF6 NSD1 BAZ1B FBXL19 SETD2 KMT2D SETBP1 KDM4A KDM4B HR | 1.41e-05 | 229 | 268 | 13 | GO:0140993 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.54e-05 | 44 | 268 | 6 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 5.36e-05 | 31 | 268 | 5 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 6.28e-05 | 32 | 268 | 5 | GO:0140457 | |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L23 USP17L1 USP17L20 MMP21 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 HTRA2 USP17L11 USP17L24 USP17L5 ADAM12 USP17L6P USP17L22 USP17L15 USP17L8 | 7.79e-05 | 654 | 268 | 22 | GO:0008233 |
| GeneOntologyMolecularFunction | demethylase activity | 2.97e-04 | 44 | 268 | 5 | GO:0032451 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 3.01e-04 | 68 | 268 | 6 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 3.26e-04 | 69 | 268 | 6 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 3.81e-04 | 71 | 268 | 6 | GO:0042054 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | ZXDC BCL9L BCL9 SRCAP ATF7IP2 THRAP3 NFE4 NSD1 FBXL19 PIAS1 PARP10 KMT2D TLE2 BRD7 SMARCA2 MYOCD YY1AP1 HR | 6.23e-04 | 562 | 268 | 18 | GO:0003712 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 7.80e-04 | 14 | 268 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 7.80e-04 | 14 | 268 | 3 | GO:0032454 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 9.65e-04 | 15 | 268 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | carnitine O-palmitoyltransferase activity | 1.06e-03 | 4 | 268 | 2 | GO:0004095 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.94e-14 | 125 | 262 | 18 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 3.62e-13 | 144 | 262 | 18 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CENPC RSF1 SRCAP UBN2 JARID2 ATF7IP2 AHR KMT2A RHNO1 BAHCC1 MEAF6 EP400 PPM1D NSD1 BAZ1B FBXL19 PIAS1 IWS1 PARP10 SETD2 KMT2D KANSL1 POLR1E SETBP1 BRD7 SMARCA2 MYOCD KDM4A ZNF518B NFAT5 KDM4B HR | 1.50e-06 | 999 | 262 | 32 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | RSF1 SRCAP UBN2 JARID2 ATF7IP2 KMT2A RHNO1 BAHCC1 MEAF6 EP400 PPM1D NSD1 BAZ1B FBXL19 IWS1 PARP10 SETD2 KMT2D KANSL1 SETBP1 BRD7 SMARCA2 MYOCD KDM4A ZNF518B NFAT5 KDM4B HR | 1.12e-05 | 896 | 262 | 28 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.11e-05 | 15 | 262 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 6.77e-05 | 18 | 262 | 4 | GO:1903385 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L RSF1 BCL9 SRCAP ADAR FANCA CHMP7 JARID2 IRF9 CRNKL1 CACTIN NUP37 AHR KMT2A THRAP3 EXOSC10 POLR1A AFF2 EP400 NSD1 NOL11 BAZ1B E2F6 RFX5 ELL3 CRY2 MLXIPL KMT2D KANSL1 POLR1E NAT10 BRD7 SMARCA2 MYOCD YY1AP1 CDC5L HR | 2.21e-05 | 1377 | 272 | 37 | GO:0140513 |
| GeneOntologyCellularComponent | pericentric heterochromatin | 5.43e-05 | 32 | 272 | 5 | GO:0005721 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 SRXN1 USP17L21 ABCA1 EMC1 USP17L1 DHRS3 USP17L20 SEC24A USP17L19 GRAMD4 USP17L18 USP17L17 OSBPL6 USP17L3 SEC23B USP17L13 SEC16B NEU4 USP17L4 USP17L12 HTRA2 ATP13A1 USP17L11 USP17L5 GRIA1 PLCD4 PLPP3 USP17L6P REEP4 USP17L22 USP17L15 USP17L8 SORL1 | 7.49e-05 | 1293 | 272 | 34 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 SRXN1 USP17L21 ABCA1 EMC1 USP17L1 DHRS3 USP17L20 SEC24A USP17L19 GRAMD4 USP17L18 USP17L17 OSBPL6 USP17L3 SEC23B USP17L13 SEC16B NEU4 USP17L4 USP17L12 HTRA2 ATP13A1 USP17L11 USP17L5 GRIA1 PLCD4 PLPP3 USP17L6P REEP4 USP17L22 USP17L15 USP17L8 SORL1 | 8.19e-05 | 1299 | 272 | 34 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 SRXN1 USP17L21 ABCA1 EMC1 USP17L1 DHRS3 USP17L20 SEC24A USP17L19 GRAMD4 USP17L18 USP17L17 OSBPL6 USP17L3 SEC23B USP17L13 SEC16B NEU4 USP17L4 USP17L12 HTRA2 ATP13A1 USP17L11 USP17L5 GRIA1 PLCD4 PLPP3 USP17L6P REEP4 USP17L22 USP17L15 USP17L8 SORL1 | 1.23e-04 | 1327 | 272 | 34 | GO:0042175 |
| GeneOntologyCellularComponent | nuclear body | CENPC MCIDAS SRCAP PHAX ADAR CRNKL1 CACTIN THRAP3 DOCK1 AFF2 EP400 CARMIL1 RMI2 PTPN23 DGKZ PIAS1 ELL3 CRY2 TLE2 SETBP1 ZFHX3 YY1AP1 MORC3 CDC5L SON HR | 1.36e-04 | 903 | 272 | 26 | GO:0016604 |
| GeneOntologyCellularComponent | chromatin | CENPC RSF1 SRCAP FANCA CHMP7 JARID2 IRF9 AHR DMRT1 HSF2 SHLD3 RHNO1 MEAF6 NCAPD3 EXOSC10 EP400 HTRA2 NSD1 BAZ1B E2F6 RFX5 PIAS1 TFE3 MLXIPL KANSL1 BRD7 SMARCA2 ANKRD11 ZFHX3 MYOCD YY1AP1 KDM4A MORC3 NFAT5 KDM4B HR | 2.14e-04 | 1480 | 272 | 36 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.60e-04 | 96 | 272 | 7 | GO:0070603 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.36e-04 | 75 | 272 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | nuclear speck | ADAR CRNKL1 CACTIN THRAP3 DOCK1 AFF2 EP400 CARMIL1 RMI2 DGKZ PIAS1 ELL3 CRY2 CDC5L SON | 5.61e-04 | 431 | 272 | 15 | GO:0016607 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.08e-03 | 16 | 272 | 3 | GO:0070021 | |
| HumanPheno | Bicuspid aortic valve | ARHGAP31 ROBO4 POLR1A PPM1D BAZ1B TGFB3 MLXIPL KMT2D KANSL1 MYOCD YY1AP1 | 2.78e-06 | 119 | 83 | 11 | HP:0001647 |
| HumanPheno | Abnormal aortic valve cusp morphology | ARHGAP31 ROBO4 POLR1A PPM1D BAZ1B TGFB3 MLXIPL KMT2D KANSL1 MYOCD YY1AP1 | 3.27e-06 | 121 | 83 | 11 | HP:0031567 |
| HumanPheno | Congenital malformation of the great arteries | STK36 MCIDAS PEX1 MMP21 SRCAP FANCA ARHGAP31 KMT2A POLR1A HTRA2 NSD1 BAZ1B TGFB3 IGBP1 KMT2D KANSL1 SMARCA2 CFAP74 MYOCD YY1AP1 SON SOS2 | 2.34e-05 | 529 | 83 | 22 | HP:0011603 |
| HumanPheno | Abnormal middle ear morphology | STK36 MCIDAS SRCAP KMT2A CARMIL2 POLR1A NSD1 BAZ1B RFX5 TFE3 MLXIPL SETD2 KMT2D KANSL1 IL21R SETBP1 ANKRD11 CFAP74 | 3.97e-05 | 390 | 83 | 18 | HP:0008609 |
| HumanPheno | Abnormal aortic valve morphology | MMP21 FANCA ARHGAP31 ROBO4 POLR1A HCN4 PPM1D BAZ1B TGFB3 MLXIPL KMT2D KANSL1 MYOCD YY1AP1 SON | 5.15e-05 | 289 | 83 | 15 | HP:0001646 |
| HumanPheno | Otitis media | STK36 MCIDAS SRCAP KMT2A CARMIL2 POLR1A NSD1 BAZ1B RFX5 TFE3 MLXIPL SETD2 KMT2D KANSL1 IL21R ANKRD11 CFAP74 | 5.64e-05 | 363 | 83 | 17 | HP:0000388 |
| HumanPheno | Abnormal morphology of the great vessels | STK36 MCIDAS PEX1 MMP21 SRCAP ADAR FANCA ARHGAP31 KMT2A ROBO4 POLR1A HTRA2 NSD1 BAZ1B TGFB3 MLXIPL IGBP1 KMT2D KANSL1 SMARCA2 CFAP74 MYOCD YY1AP1 EIF2AK4 SON SOS2 | 6.21e-05 | 736 | 83 | 26 | HP:0030962 |
| HumanPheno | Coronary artery stenosis | 8.05e-05 | 6 | 83 | 3 | HP:0005145 | |
| HumanPheno | Abnormal cardiac atrium morphology | STK36 MCIDAS MPDZ MMP21 MCM10 SRCAP FANCA ARHGAP31 KMT2A ROBO4 POLR1A NSD1 BAZ1B FHOD3 TGFB3 MLXIPL KMT2D KANSL1 SETBP1 CFAP74 MYOCD SON SOS2 | 8.40e-05 | 617 | 83 | 23 | HP:0005120 |
| HumanPheno | Abnormal fingertip morphology | STK36 EMC1 MARS1 MCIDAS SRCAP FANCA JARID2 KMT2D KANSL1 SMARCA2 CFAP74 EIF2AK4 | 9.26e-05 | 203 | 83 | 12 | HP:0001211 |
| HumanPheno | Generalized hypertrichosis | 1.39e-04 | 7 | 83 | 3 | HP:0004554 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.80e-22 | 16 | 259 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.80e-22 | 16 | 259 | 13 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.91e-15 | 71 | 259 | 16 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.91e-15 | 71 | 259 | 16 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 2.42e-15 | 72 | 259 | 16 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 2.42e-15 | 72 | 259 | 16 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 2.42e-15 | 72 | 259 | 16 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.28e-14 | 66 | 259 | 15 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 3.28e-14 | 70 | 259 | 15 | PS00972 |
| Domain | PHD | 4.30e-07 | 89 | 259 | 10 | SM00249 | |
| Domain | Znf_PHD | 5.30e-07 | 91 | 259 | 10 | IPR001965 | |
| Domain | ZF_PHD_2 | 7.94e-07 | 95 | 259 | 10 | PS50016 | |
| Domain | ZF_PHD_1 | 8.76e-07 | 96 | 259 | 10 | PS01359 | |
| Domain | PHD | 9.28e-06 | 75 | 259 | 8 | PF00628 | |
| Domain | HSA | 1.04e-05 | 4 | 259 | 3 | SM00573 | |
| Domain | HSA | 1.04e-05 | 4 | 259 | 3 | PS51204 | |
| Domain | HSA_dom | 1.04e-05 | 4 | 259 | 3 | IPR014012 | |
| Domain | HSA | 1.04e-05 | 4 | 259 | 3 | PF07529 | |
| Domain | Znf_PHD-finger | 1.37e-05 | 79 | 259 | 8 | IPR019787 | |
| Domain | Znf_FYVE_PHD | 3.97e-05 | 147 | 259 | 10 | IPR011011 | |
| Domain | Post-SET_dom | 5.77e-05 | 16 | 259 | 4 | IPR003616 | |
| Domain | PostSET | 5.77e-05 | 16 | 259 | 4 | SM00508 | |
| Domain | POST_SET | 5.77e-05 | 16 | 259 | 4 | PS50868 | |
| Domain | BCL9 | 1.92e-04 | 2 | 259 | 2 | PF11502 | |
| Domain | TMEM131-like | 1.92e-04 | 2 | 259 | 2 | IPR022113 | |
| Domain | TMEM131_like | 1.92e-04 | 2 | 259 | 2 | PF12371 | |
| Domain | Bcl-9 | 1.92e-04 | 2 | 259 | 2 | IPR015668 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.92e-04 | 2 | 259 | 2 | IPR024670 | |
| Domain | EPHD | 2.17e-04 | 22 | 259 | 4 | PS51805 | |
| Domain | JmjN | 2.94e-04 | 10 | 259 | 3 | SM00545 | |
| Domain | JmjN | 2.94e-04 | 10 | 259 | 3 | PF02375 | |
| Domain | JMJN | 2.94e-04 | 10 | 259 | 3 | PS51183 | |
| Domain | JmjN | 2.94e-04 | 10 | 259 | 3 | IPR003349 | |
| Domain | JmjC | 3.09e-04 | 24 | 259 | 4 | PF02373 | |
| Domain | GAIN_dom_N | 4.01e-04 | 11 | 259 | 3 | IPR032471 | |
| Domain | GAIN | 4.01e-04 | 11 | 259 | 3 | PF16489 | |
| Domain | GPCR_2_brain_angio_inhib | 5.69e-04 | 3 | 259 | 2 | IPR008077 | |
| Domain | CARMIL_C | 5.69e-04 | 3 | 259 | 2 | IPR031943 | |
| Domain | CARMIL_C | 5.69e-04 | 3 | 259 | 2 | PF16000 | |
| Domain | NPIP | 8.57e-04 | 14 | 259 | 3 | IPR009443 | |
| Domain | JMJC | 9.57e-04 | 32 | 259 | 4 | PS51184 | |
| Domain | JmjC_dom | 9.57e-04 | 32 | 259 | 4 | IPR003347 | |
| Domain | JmjC | 1.08e-03 | 33 | 259 | 4 | SM00558 | |
| Domain | DnaJ | 1.13e-03 | 4 | 259 | 2 | IPR012724 | |
| Domain | DnaJ_CXXCXGXG | 1.13e-03 | 4 | 259 | 2 | PF00684 | |
| Domain | - | 1.13e-03 | 4 | 259 | 2 | 2.10.230.10 | |
| Domain | ZF_CR | 1.13e-03 | 4 | 259 | 2 | PS51188 | |
| Domain | FYrich_C | 1.86e-03 | 5 | 259 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.86e-03 | 5 | 259 | 2 | IPR003888 | |
| Domain | AWS | 1.86e-03 | 5 | 259 | 2 | SM00570 | |
| Domain | FYRC | 1.86e-03 | 5 | 259 | 2 | SM00542 | |
| Domain | FYRN | 1.86e-03 | 5 | 259 | 2 | SM00541 | |
| Domain | AWS | 1.86e-03 | 5 | 259 | 2 | PS51215 | |
| Domain | AWS_dom | 1.86e-03 | 5 | 259 | 2 | IPR006560 | |
| Domain | WHIM1_dom | 1.86e-03 | 5 | 259 | 2 | IPR028942 | |
| Domain | HSP_DnaJ_Cys-rich_dom | 1.86e-03 | 5 | 259 | 2 | IPR001305 | |
| Domain | WHIM1 | 1.86e-03 | 5 | 259 | 2 | PF15612 | |
| Domain | FYRN | 1.86e-03 | 5 | 259 | 2 | PF05964 | |
| Domain | FYRC | 1.86e-03 | 5 | 259 | 2 | PF05965 | |
| Domain | FYRC | 1.86e-03 | 5 | 259 | 2 | PS51543 | |
| Domain | FYRN | 1.86e-03 | 5 | 259 | 2 | PS51542 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.94e-20 | 45 | 203 | 17 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.26e-09 | 191 | 203 | 17 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L15 USP17L8 | 1.26e-07 | 221 | 203 | 16 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.44e-07 | 262 | 203 | 17 | MM15286 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 LRRC7 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 8.01e-07 | 318 | 203 | 18 | MM15278 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L15 USP17L8 | 6.88e-06 | 299 | 203 | 16 | M27574 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.51e-33 | 21 | 275 | 17 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.51e-33 | 21 | 275 | 17 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.51e-33 | 21 | 275 | 17 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.51e-33 | 21 | 275 | 17 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.51e-33 | 21 | 275 | 17 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.51e-33 | 21 | 275 | 17 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.84e-32 | 22 | 275 | 17 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 3.69e-31 | 24 | 275 | 17 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.14e-30 | 25 | 275 | 17 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 3.28e-30 | 26 | 275 | 17 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 7.75e-30 | 33 | 275 | 18 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-29 | 34 | 275 | 18 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 3.34e-29 | 35 | 275 | 18 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 3.34e-29 | 35 | 275 | 18 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 5.34e-29 | 29 | 275 | 17 | 32527007 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.64e-29 | 36 | 275 | 18 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.28e-28 | 37 | 275 | 18 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 8.73e-24 | 50 | 275 | 17 | 31806660 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES EMC1 SEC24A SIPA1L3 KCTD8 CCDC18 MPDZ EDC4 MAST2 PRAG1 SPICE1 WWC2 PHLDB1 SYNJ2 OSBPL6 MAP3K9 KMT2A HELZ CAMSAP2 ABTB2 SEC23B CARMIL2 SASH1 CARMIL1 AAK1 FAM171A1 MLXIPL EIF4G1 ANKRD11 REEP4 PEAK1 MORC3 CDC25B CRTC2 | 1.58e-14 | 861 | 275 | 34 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZNF318 BCL9 SPICE1 CACTIN WWC2 FASN SSH1 ZC3H4 KMT2A HELZ TLN2 THRAP3 SEC16B NCAPD3 EP400 CARMIL1 PHRF1 NUMA1 AAK1 BAZ1B DIDO1 URGCP IWS1 SETD2 KMT2D KANSL1 FHOD1 EIF4G1 SMARCA2 YY1AP1 KDM4B SON | 2.85e-14 | 774 | 275 | 32 | 15302935 |
| Pubmed | BCL9L EMC1 MARS1 SIPA1L3 MPDZ ZNF318 EDC4 UBN2 JARID2 CRNKL1 NUP37 GOLIM4 KMT2A HELZ LAMTOR1 CAMSAP2 MOV10 NCAPD3 POLR1A EP400 ATP13A1 PHRF1 AAK1 PCDHB7 NSD1 TRIOBP NOL11 BAZ1B DIDO1 DGKZ ANKZF1 PIAS1 IWS1 SETD2 CELSR1 POLR1E BRD7 EIF4G1 SMARCA2 ANKRD11 ZFHX3 MRPL38 REEP4 SON | 5.78e-14 | 1497 | 275 | 44 | 31527615 | |
| Pubmed | TNIK NES ILF2 DNAJA2 SIPA1L3 ADGRB2 MPDZ ZNF318 EDC4 BCL9 UBN2 SPICE1 SSH1 DNAJA4 ZC3H4 TLN2 LRRC7 LAMTOR1 CAMSAP2 THRAP3 HCN4 WDR7 NUMA1 AAK1 NSD1 TRIOBP GRIA1 DIDO1 DGKZ FAM171A1 PLPP3 NAT10 BRD7 EIF4G1 CDC5L | 7.14e-14 | 963 | 275 | 35 | 28671696 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 2.11e-13 | 10 | 275 | 7 | 24207026 | |
| Pubmed | USP17L7 SRXN1 USP17L21 ABCA1 USP17L1 DHRS3 PSG1 PSG3 USP17L20 PSG9 ADGRB1 ZC3H12B USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 IGBP1 KMT2D USP17L6P DDX3Y USP17L22 USP17L15 USP17L8 | 1.15e-12 | 674 | 275 | 28 | 37196079 | |
| Pubmed | 1.37e-12 | 12 | 275 | 7 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 5.86e-12 | 14 | 275 | 7 | 11793228 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ILF2 DNAJA2 ZNF318 SRCAP UBN2 ADAR FANCA CACTIN KMT2A THRAP3 MEAF6 NCAPD3 EXOSC10 EP400 CTDSPL2 PHRF1 RMI2 NUMA1 NSD1 NOL11 BAZ1B DIDO1 E2F6 CPT1A RFX5 TFE3 IWS1 MLXIPL SETD2 KMT2D KANSL1 POLR1E NAT10 ANKRD11 REEP4 CDC5L SON | 1.60e-11 | 1294 | 275 | 37 | 30804502 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC SRXN1 STK36 SIPA1L3 ADGRB2 EDC4 BCL9 SRCAP MAST2 PRAG1 FANCA FASN PHLDB1 TNRC18 EHBP1L1 SSH1 TLN2 ABTB2 ARAP1 BAHCC1 NDST1 EP400 ATP13A1 NSD1 FBXL19 TFE3 HIVEP3 CELSR1 KMT2D KANSL1 EIF4G1 ANKRD11 HR | 7.26e-11 | 1105 | 275 | 33 | 35748872 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 8.32e-11 | 19 | 275 | 7 | 28067227 | |
| Pubmed | BCL9L ILF2 MARS1 SEC24A DNAJA2 ZNF318 EDC4 BCL9 SRCAP UBN2 FHAD1 IRF9 KMT2A HELZ SEC23B MOV10 MEAF6 EP400 SOBP NUMA1 BAZ1B DIDO1 E2F6 RFX5 PIAS1 TFE3 KMT2D KANSL1 WDCP NAT10 BRD7 EIF4G1 SMARCA2 ZFHX3 YY1AP1 MRPL38 SORL1 | 2.61e-10 | 1429 | 275 | 37 | 35140242 | |
| Pubmed | MPDZ ZNF318 EDC4 SRCAP PHAX UBN2 ADAR FASN KMT2A THRAP3 EXOSC10 EP400 NUMA1 NSD1 BAZ1B PTPN23 DIDO1 SETD2 KMT2D NAT10 PEAK1 CDC5L | 6.53e-10 | 549 | 275 | 22 | 38280479 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ILF2 CENPC RSF1 ZNF318 UBN2 ADAR PRAM1 CRNKL1 ZC3H4 KMT2A SPATA22 THRAP3 MEAF6 EXOSC10 EP400 NUMA1 NSD1 NOL11 BAZ1B DIDO1 RFX5 SETD2 NAT10 BRD7 EIF4G1 ANKRD11 DDX3Y CDC5L SON | 7.48e-10 | 954 | 275 | 29 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CENPC RSF1 MCM10 SRCAP PHAX UBN2 CACTIN KMT2A MEAF6 CTDSPL2 NUMA1 NSD1 BAZ1B DIDO1 RFX5 PIAS1 IWS1 POLR1E NAT10 BRD7 KDM4A MORC3 KDM4B | 7.98e-10 | 608 | 275 | 23 | 36089195 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DHRS3 MARS1 SIPA1L3 UBN2 PHKB PHLDB1 TNRC18 POGLUT1 SYNJ2 ASTN2 LRRC7 ANKRD12 THRAP3 NSMAF ARAP1 DOCK1 PRUNE2 POLR1A SOBP CARMIL1 AAK1 TRIOBP CPT1A SHROOM2 HIVEP3 PARP10 SETBP1 NAT10 SMARCA2 ANKRD11 ZFHX3 TTC17 EIF2AK4 NFAT5 GPA33 KDM4B SOS2 | 8.04e-10 | 1489 | 275 | 37 | 28611215 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CENPC DNAJA2 SIPA1L3 TUBGCP2 EDC4 SPICE1 PHKB CRNKL1 FASN SYNJ2 DNAJA4 ZC3H4 NUP37 TLN2 HSF2 THRAP3 MOV10 ARAP1 CARMIL1 RMI2 NUMA1 TRIOBP CRY2 IGBP1 KANSL1 WDCP BRD7 EIF4G1 SMARCA2 MORC3 CDC5L CDC25B | 9.22e-10 | 1155 | 275 | 32 | 20360068 |
| Pubmed | EMC1 GRAMD4 SYNJ2 ARHGAP31 ZC3H4 TMEM131L ARAP1 NCAPD3 SASH1 EP400 PHRF1 AAK1 TRIOBP DIDO1 URGCP IBTK SETBP1 NAT10 KDM4A EIF2AK4 KDM4B | 1.91e-09 | 529 | 275 | 21 | 14621295 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK MARS1 RSF1 ZNF318 EDC4 SRCAP PHAX ADAR FASN ZC3H4 KMT2A HELZ CAMSAP2 EXOSC10 EP400 CARMIL1 NUMA1 AAK1 BAZ1B PTPN23 DIDO1 IBTK SETD2 IGBP1 FHOD1 NAT10 CDC5L SON | 2.03e-09 | 934 | 275 | 28 | 33916271 |
| Pubmed | EMC1 PEX1 MPDZ MAST2 FANCA ZC3H4 KMT2A HELZ SEC23B NCAPD3 GRB7 DIDO1 ANKZF1 PIAS1 URGCP IBTK WDCP YY1AP1 EIF2AK4 CDC25B CRTC2 SORL1 HR | 2.84e-09 | 650 | 275 | 23 | 38777146 | |
| Pubmed | NES ILF2 RSF1 ZNF318 EDC4 CRNKL1 FASN KMT2A HELZ SEC23B MOV10 EXOSC10 POLR1A PHRF1 NUMA1 NSD1 NOL11 BAZ1B DIDO1 NAT10 EIF4G1 SMARCA2 SON | 3.10e-09 | 653 | 275 | 23 | 22586326 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | UBL7 PEX1 MAST2 ADAR SSH1 HELZ THRAP3 MOV10 DOCK1 POLR1A NOL11 CRY2 CDC25B SON | 5.82e-09 | 232 | 275 | 14 | 25515538 |
| Pubmed | ILF2 CENPC DNAJA2 RSF1 PHAX ADAR CRNKL1 CACTIN FASN UBE2E1 KMT2A THRAP3 EXOSC10 POLR1A EP400 NUMA1 NOL11 BAZ1B DIDO1 PIAS1 IWS1 SETD2 POLR1E NAT10 EIF4G1 SMARCA2 CDC5L SON | 1.20e-08 | 1014 | 275 | 28 | 32416067 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | STK36 BCL9 ZNF469 TNRC18 ARHGAP31 ATF7IP2 ARAP1 DOCK1 PRUNE2 AFF2 EP400 CTDSPL2 NUMA1 PIAS1 SETBP1 CRTC2 SON SOS2 | 1.26e-08 | 430 | 275 | 18 | 35044719 |
| Pubmed | STK36 SIPA1L3 UBN2 ELFN2 TNRC18 SSH1 ASTN2 MOV10 PRUNE2 SEC16B ATP13A1 PTPN23 CRY2 HIVEP3 SETD2 ZNF518B PEAK1 MORC3 CDC5L | 1.85e-08 | 493 | 275 | 19 | 15368895 | |
| Pubmed | ATP7B DNAJA2 RSF1 PEX1 MMP21 ZNF318 TUBGCP2 SRCAP MAST2 CACTIN ZNF469 ZC3H4 AHR HELZ BAHCC1 MEAF6 EP400 PHRF1 BAZ1B ELL3 SETD2 POLR1E IL21R NAT10 BRD7 SMARCA2 ZFHX3 SON SORL1 | 2.42e-08 | 1116 | 275 | 29 | 31753913 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L BCL9 UBN2 TNRC18 KMT2A BAHCC1 MEAF6 EP400 SOBP BAZ1B E2F6 PIAS1 KMT2D BRD7 SMARCA2 ZFHX3 | 2.55e-08 | 351 | 275 | 16 | 38297188 |
| Pubmed | TNIK SIPA1L3 PHLDB1 ZC3H4 TLN2 ARAP1 PRUNE2 TRIOBP PTPN23 SETBP1 GRIP2 CDC5L KDM4B | 3.43e-08 | 225 | 275 | 13 | 12168954 | |
| Pubmed | ZXDC ZNF318 SRCAP JARID2 AHR DMRT1 ABTB2 IKZF2 BAZ1B DIDO1 E2F6 FBXL19 RFX5 PIAS1 TFE3 HIVEP3 IBTK BRD7 SMARCA2 ZFHX3 KDM4A CDC5L NFAT5 KDM4B | 3.63e-08 | 808 | 275 | 24 | 20412781 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES ILF2 CENPC MARS1 DNAJA2 RSF1 MCM10 SRCAP ADAR CRNKL1 FASN PHLDB1 CORO7 THRAP3 MOV10 EXOSC10 POLR1A EP400 NUMA1 AAK1 NOL11 BAZ1B PTPN23 RIN1 KANSL1 POLR1E FHOD1 NAT10 EIF4G1 SMARCA2 CDC5L SON | 3.91e-08 | 1353 | 275 | 32 | 29467282 |
| Pubmed | NES ILF2 MARS1 DNAJA2 SIPA1L3 EDC4 ELFN2 PHKB FASN PHLDB1 MGAT3 OSBPL6 KMT2A TLN2 LRRC7 CORO7 CAMSAP2 THRAP3 UQCRFS1P1 CARMIL2 WDR7 CARMIL1 AAK1 GRIA1 DGKZ BCAS1 SHROOM2 RIN1 MLXIPL EIF4G1 DDX3Y PEAK1 CDC5L | 4.26e-08 | 1431 | 275 | 33 | 37142655 | |
| Pubmed | BCL9L RSF1 JARID2 CRNKL1 CACTIN SSH1 ZC3H4 KMT2A MOV10 EP400 NUMA1 PLCD4 IWS1 IBTK KMT2D BRD7 MORC3 CDC5L | 4.70e-08 | 469 | 275 | 18 | 27634302 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ZNF318 PHAX ADAR CACTIN ZC3H4 THRAP3 EXOSC10 EP400 NUMA1 NOL11 BAZ1B DIDO1 NAT10 ZFHX3 | 7.07e-08 | 283 | 275 | 14 | 30585729 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TNIK SEC24A EDC4 PHAX SPICE1 CHMP7 WWC2 PHLDB1 DNAJA4 AHR CAMSAP2 THRAP3 ABTB2 SEC23B FBXW10 AAK1 DGKZ ANKZF1 TFE3 IWS1 CRY2 MLXIPL SETD2 WDCP ARHGAP12 CDC25B CRTC2 | 7.44e-08 | 1038 | 275 | 27 | 26673895 |
| Pubmed | ILF2 CENPC ZNF318 MCM10 CRNKL1 CACTIN KMT2A EXOSC10 EP400 NOL11 DIDO1 E2F6 NAT10 YY1AP1 CDC5L | 1.03e-07 | 339 | 275 | 15 | 30415952 | |
| Pubmed | RSF1 ADAR CHMP7 FASN ZC3H4 TLN2 BCAR3 THRAP3 DOCK1 NUMA1 AAK1 DIDO1 ANKZF1 IWS1 RIN1 EIF4G1 TMEM131 SON | 1.33e-07 | 503 | 275 | 18 | 16964243 | |
| Pubmed | SRXN1 ILF2 MARS1 PEX1 ZNF318 SRCAP UBN2 PHKB WWC2 MAP3K9 TMEM131L ANKRD12 EXOSC10 NSD1 NOL11 BAZ1B PTPN23 DIDO1 DGKZ CPT2 SHROOM2 NAT10 DDX3Y TMEM131 EIF2AK4 PEAK1 NFAT5 | 1.76e-07 | 1084 | 275 | 27 | 11544199 | |
| Pubmed | BCL9L STK36 ILF2 DHRS3 DNAJA2 PEX1 EDC4 FASN PHLDB1 DNAJA4 MOV10 UQCRFS1P1 EP400 WDR7 BAZ1B PTPN23 DIDO1 SETD2 POLR1E NAT10 EIF4G1 GRIP2 | 1.86e-07 | 754 | 275 | 22 | 35906200 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | ADAR CRNKL1 THRAP3 NUMA1 DIDO1 PIAS1 KMT2D SMARCA2 ZFHX3 MORC3 CDC5L SON | 2.17e-07 | 220 | 275 | 12 | 35785414 |
| Pubmed | EMC1 CENPC SEC24A DNAJA2 SIPA1L3 CCDC18 SPICE1 PHKB CACTIN WWC2 SSH1 GOLIM4 HELZ CTDSPL2 PPM1D TRIOBP PTPN23 IWS1 FAM171A1 IGBP1 KMT2D NAT10 EIF2AK4 PEAK1 CDC5L CDC25B | 3.31e-07 | 1049 | 275 | 26 | 27880917 | |
| Pubmed | 4.89e-07 | 3 | 275 | 3 | 2341148 | ||
| Pubmed | SRCAP JARID2 EP400 BAZ1B KMT2D BRD7 SMARCA2 ANKRD11 KDM4A KDM4B | 5.47e-07 | 157 | 275 | 10 | 30186101 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | TUBGCP2 EDC4 SRCAP CRNKL1 ZC3H4 KMT2A THRAP3 NCAPD3 EP400 PPM1D BAZ1B DIDO1 KMT2D YY1AP1 | 6.77e-07 | 341 | 275 | 14 | 32971831 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ILF2 DNAJA2 MCM10 PHAX ADAR HSF2 MOV10 NCAPD3 EXOSC10 POLR1A NUMA1 NOL11 BAZ1B DIDO1 URGCP IBTK POLR1E NAT10 EIF4G1 CDC5L SON | 8.40e-07 | 759 | 275 | 21 | 35915203 |
| Pubmed | ILF2 MARS1 EVPL ADAR CRNKL1 FASN ZC3H4 KMT2A THRAP3 MOV10 NCAPD3 EXOSC10 POLR1A NUMA1 NOL11 BAZ1B CPT1A NAT10 EIF4G1 CDC5L NFAT5 SON | 1.30e-06 | 847 | 275 | 22 | 35850772 | |
| Pubmed | TNIK ILF2 SIPA1L3 PHAX CRNKL1 CACTIN FASN AHR KMT2A THRAP3 MOV10 UQCRFS1P1 MEAF6 SEC16B EXOSC10 EP400 ATP13A1 NUMA1 AAK1 NOL11 DIDO1 ANKZF1 IBTK NAT10 BRD7 EIF4G1 DDX3Y EIF2AK4 SON | 1.70e-06 | 1371 | 275 | 29 | 36244648 | |
| Pubmed | BCL9L BCL9 UBN2 TNRC18 ZC3H4 KMT2A EXOSC10 EP400 RFX5 KMT2D BRD7 SMARCA2 | 1.75e-06 | 268 | 275 | 12 | 33640491 | |
| Pubmed | TNIK NES ATP7B DNAJA2 MPDZ MCM10 TUBGCP2 SYNJ2 TMEM131L HELZ CORO7 POLR1A EP400 ATP13A1 IBTK SETD2 TTC17 TMEM131 REEP4 CDC5L | 1.91e-06 | 733 | 275 | 20 | 34672954 | |
| Pubmed | 2.43e-06 | 49 | 275 | 6 | 34368113 | ||
| Pubmed | BCL9L ADAR CHMP7 FASN TNRC18 ZC3H4 NUMA1 NSD1 BAZ1B EIF4G1 ANKRD11 ZNF518B SON | 2.86e-06 | 332 | 275 | 13 | 37433992 | |
| Pubmed | 3.78e-06 | 81 | 275 | 7 | 12838346 | ||
| Pubmed | 3.90e-06 | 195 | 275 | 10 | 19454010 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TUBGCP2 EDC4 FASN NUP37 TLN2 THRAP3 SEC23B ARAP1 DOCK1 EXOSC10 PPM1D KANSL1 FHOD1 NAT10 BRD7 SMARCA2 CDC5L | 4.70e-06 | 582 | 275 | 17 | 20467437 |
| Pubmed | Insulin acutely decreases hepatic fatty acid synthase activity. | 4.87e-06 | 15 | 275 | 4 | 16054098 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | PHKB FASN ZC3H4 DOCK1 NCAPD3 NUMA1 EIF4G1 SMARCA2 TTC17 EIF2AK4 | 5.33e-06 | 202 | 275 | 10 | 33005030 |
| Pubmed | EDC4 FASN KMT2A THRAP3 NCAPD3 POLR1A NUMA1 PTPN23 CPT1A EIF4G1 | 5.33e-06 | 202 | 275 | 10 | 24639526 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | ILF2 DNAJA2 RSF1 KMT2A THRAP3 EP400 CTDSPL2 BAZ1B PIAS1 NAT10 SMARCA2 MORC3 CDC5L SON | 5.93e-06 | 411 | 275 | 14 | 35182466 |
| Pubmed | 5.99e-06 | 57 | 275 | 6 | 18022353 | ||
| Pubmed | NES ILF2 SEC24A PHAX ADAR ZC3H4 TLN2 EP400 PTPN23 DIDO1 RIN1 FHOD1 BRD7 SMARCA2 DDX3Y | 6.35e-06 | 472 | 275 | 15 | 38943005 | |
| Pubmed | Regulation of the epithelial adhesion molecule CEACAM1 is important for palate formation. | 6.46e-06 | 16 | 275 | 4 | 23613893 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ILF2 MARS1 ADAR CRNKL1 CACTIN FASN UBE2E1 KMT2A HELZ THRAP3 SEC23B MOV10 UQCRFS1P1 POLR1A EP400 NUMA1 NOL11 BAZ1B DIDO1 POLR1E NAT10 EIF4G1 SMARCA2 DDX3Y MORC3 CDC5L SON | 7.06e-06 | 1318 | 275 | 27 | 30463901 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L SRXN1 SIPA1L3 MAST2 CCDC88B CRNKL1 PHLDB1 TLN2 THRAP3 SEC16B DIDO1 EIF4G1 SON | 7.07e-06 | 361 | 275 | 13 | 26167880 |
| Pubmed | TNIK ILF2 EMC1 CENPC DNAJA2 CCDC18 MPDZ ECSIT SPICE1 CHMP7 CACTIN DNAJA4 TMEM131L LAMTOR1 EXOSC10 ATP13A1 TRIOBP NOL11 BAZ1B E2F6 FAM171A1 NAT10 ANKRD11 TTC17 TMEM131 MRPL38 REEP4 PEAK1 CDC5L | 8.10e-06 | 1487 | 275 | 29 | 33957083 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES ILF2 EMC1 MARS1 ZNF318 EDC4 SRCAP ADAR CRNKL1 FASN PHLDB1 ZC3H4 THRAP3 EXOSC10 POLR1A EP400 NUMA1 NOL11 BAZ1B NAT10 EIF4G1 CDC5L SON | 8.18e-06 | 1024 | 275 | 23 | 24711643 |
| Pubmed | 9.61e-06 | 6 | 275 | 3 | 16514417 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 9.75e-06 | 130 | 275 | 8 | 35545047 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | ILF2 MARS1 DNAJA2 ADAR FASN THRAP3 EXOSC10 NAT10 EIF4G1 CDC5L | 1.17e-05 | 221 | 275 | 10 | 29991511 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ZNF318 SRCAP ADAR NUP37 MOV10 EXOSC10 POLR1A EP400 NUMA1 SETD2 WDCP NAT10 BRD7 SMARCA2 | 1.28e-05 | 440 | 275 | 14 | 34244565 |
| Pubmed | PEX1 ZNF318 SRCAP PHAX CRNKL1 CACTIN FASN DNAJA4 ZC3H4 THRAP3 EP400 NUMA1 TTC17 CDC5L SON | 1.44e-05 | 506 | 275 | 15 | 30890647 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TNIK ILF2 EMC1 DNAJA2 ADAR FASN SEC23B MOV10 NCAPD3 POLR1A HDHD5 NUMA1 NOL11 BAZ1B PTPN23 SMARCA2 DDX3Y SON | 1.50e-05 | 704 | 275 | 18 | 29955894 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | MARS1 EDC4 SRCAP FASN NCAPD3 EXOSC10 EP400 NUMA1 DIDO1 NAT10 EIF4G1 MORC3 | 1.54e-05 | 332 | 275 | 12 | 32786267 |
| Interaction | YWHAG interactions | SEC24A SIPA1L3 CCDC18 MPDZ EDC4 MAST2 PRAG1 SPICE1 WWC2 PHLDB1 SSH1 SYNJ2 OSBPL6 MAP3K9 KMT2A HELZ SLAIN1 CAMSAP2 THRAP3 SEC23B CARMIL2 SASH1 CARMIL1 AAK1 SHROOM2 PIAS1 TFE3 FAM171A1 RIN1 MLXIPL EIF4G1 ANKRD11 REEP4 PEAK1 MORC3 CDC5L CDC25B CRTC2 SON | 3.18e-07 | 1248 | 262 | 39 | int:YWHAG |
| Interaction | TLE3 interactions | BCL9L SRXN1 SEC24A ZNF318 BCL9 UBN2 CACTIN TNRC18 KMT2A HELZ PIAS1 SETD2 IGBP1 KMT2D WDCP TLE2 ZFHX3 CRTC2 SON | 5.36e-07 | 376 | 262 | 19 | int:TLE3 |
| Interaction | H2BC8 interactions | CENPC RSF1 MCM10 SRCAP CACTIN KMT2A MEAF6 EXOSC10 EP400 CTDSPL2 NUMA1 NSD1 NOL11 BAZ1B DIDO1 E2F6 RFX5 PIAS1 IWS1 IGBP1 NAT10 BRD7 MORC3 KDM4B | 5.75e-07 | 576 | 262 | 24 | int:H2BC8 |
| Interaction | NUP43 interactions | BCL9L CENPC DNAJA2 RSF1 ZNF318 SRCAP UBN2 CACTIN NUP37 KMT2A HSF2 EP400 PHRF1 NSD1 NOL11 E2F6 IWS1 SETD2 KMT2D KANSL1 POLR1E EIF4G1 ANKRD11 ZFHX3 SON | 7.01e-07 | 625 | 262 | 25 | int:NUP43 |
| Interaction | H3-3A interactions | CENPC RSF1 MCM10 SRCAP PHAX UBN2 CACTIN KMT2A THRAP3 MEAF6 CTDSPL2 PPM1D NUMA1 NSD1 BAZ1B DIDO1 RFX5 PIAS1 TFE3 IWS1 PARP10 KMT2D NAT10 BRD7 KDM4A MORC3 KDM4B | 1.82e-06 | 749 | 262 | 27 | int:H3-3A |
| Interaction | EGR2 interactions | BCL9L BCL9 UBN2 TNRC18 KMT2A BAHCC1 MEAF6 EP400 KMT2D BRD7 SMARCA2 ZFHX3 | 2.56e-06 | 171 | 262 | 12 | int:EGR2 |
| Interaction | YWHAH interactions | NES EMC1 SEC24A SIPA1L3 CCDC18 MPDZ EDC4 MAST2 PRAG1 WWC2 PHLDB1 SSH1 SYNJ2 OSBPL6 MAP3K9 KMT2A SLAIN1 CAMSAP2 SEC23B CARMIL2 SASH1 CARMIL1 AAK1 TFE3 FAM171A1 RIN1 MLXIPL EIF4G1 ANKRD11 REEP4 PEAK1 MORC3 CDC25B CRTC2 | 2.62e-06 | 1102 | 262 | 34 | int:YWHAH |
| Interaction | AR interactions | BCL9L ILF2 ZNF318 BCL9 SRCAP UBN2 ADAR CRNKL1 TNRC18 ZC3H4 AHR KMT2A THRAP3 SEC23B EXOSC10 EP400 NUMA1 NSD1 GRB7 DIDO1 RFX5 PIAS1 KMT2D BRD7 SMARCA2 ZFHX3 KDM4A MORC3 CDC5L CDC25B SON | 5.84e-06 | 992 | 262 | 31 | int:AR |
| Interaction | H3C1 interactions | CENPC RSF1 SRCAP UBN2 CACTIN TNRC18 ZC3H4 KMT2A THRAP3 MOV10 EXOSC10 PPM1D NUMA1 NSD1 BAZ1B DIDO1 RFX5 PIAS1 TFE3 PARP10 SETD2 KMT2D NAT10 BRD7 EIF4G1 SMARCA2 ZFHX3 KDM4A MORC3 | 6.84e-06 | 901 | 262 | 29 | int:H3C1 |
| Interaction | TOP3B interactions | ZXDC SRXN1 STK36 SEC24A DNAJA2 SIPA1L3 ADGRB2 EDC4 BCL9 SRCAP MAST2 PRAG1 FANCA FASN PHLDB1 TNRC18 EHBP1L1 SSH1 HELZ TLN2 ABTB2 SEC23B MOV10 ARAP1 BAHCC1 NDST1 EP400 ATP13A1 NSD1 FBXL19 TFE3 HIVEP3 IBTK CELSR1 KMT2D KANSL1 EIF4G1 ANKRD11 KDM4A HR | 6.90e-06 | 1470 | 262 | 40 | int:TOP3B |
| Interaction | YWHAB interactions | EMC1 SEC24A SIPA1L3 CCDC18 MAST2 WWC2 PHLDB1 UBE2E1 SSH1 SYNJ2 OSBPL6 MAP3K9 KMT2A SLAIN1 CAMSAP2 SEC23B NCAPD3 CARMIL2 SASH1 PPM1D AAK1 TFE3 FAM171A1 RIN1 EIF4G1 REEP4 PEAK1 MORC3 CDC25B CRTC2 SON | 9.04e-06 | 1014 | 262 | 31 | int:YWHAB |
| Interaction | C2CD4B interactions | 2.13e-05 | 44 | 262 | 6 | int:C2CD4B | |
| Interaction | DHX40 interactions | CENPC ZNF318 CACTIN POGLUT1 ZC3H4 THRAP3 NSD1 E2F6 SETD2 NAT10 BRD7 ANKRD11 CDC5L | 2.45e-05 | 249 | 262 | 13 | int:DHX40 |
| Interaction | H3C3 interactions | CENPC RSF1 SRCAP CACTIN KMT2A MEAF6 CTDSPL2 NUMA1 NSD1 BAZ1B DIDO1 RFX5 PIAS1 IWS1 POLR1E NAT10 BRD7 MORC3 KDM4B | 2.81e-05 | 495 | 262 | 19 | int:H3C3 |
| Interaction | SFN interactions | TNIK SIPA1L3 CCDC18 EDC4 MAST2 WWC2 PHLDB1 SYNJ2 KMT2A CAMSAP2 SASH1 CARMIL1 AAK1 GRB7 PIAS1 TFE3 FAM171A1 IGBP1 EIF4G1 REEP4 PEAK1 CDC25B NEK11 | 3.93e-05 | 692 | 262 | 23 | int:SFN |
| Interaction | SIRT7 interactions | NES ILF2 RSF1 ZNF318 EDC4 CRNKL1 FASN KMT2A HELZ SEC23B MOV10 EXOSC10 POLR1A PHRF1 NUMA1 NSD1 NOL11 BAZ1B DIDO1 POLR1E NAT10 EIF4G1 SMARCA2 SON | 4.27e-05 | 744 | 262 | 24 | int:SIRT7 |
| Interaction | SMC5 interactions | ILF2 CENPC RSF1 ZNF318 UBN2 ADAR PRAM1 CRNKL1 ZC3H4 KMT2A SPATA22 THRAP3 MEAF6 EXOSC10 EP400 NUMA1 NSD1 NOL11 BAZ1B DIDO1 RFX5 SETD2 NAT10 BRD7 EIF4G1 ANKRD11 DDX3Y CDC5L SON | 4.68e-05 | 1000 | 262 | 29 | int:SMC5 |
| Interaction | FBXW11 interactions | UBL7 PEX1 TUBGCP2 MAST2 ADAR SSH1 HELZ THRAP3 MOV10 DOCK1 POLR1A TRIOBP NOL11 TFE3 CRY2 NAT10 CDC25B SON | 5.11e-05 | 473 | 262 | 18 | int:FBXW11 |
| Interaction | FEV interactions | BCL9 UBN2 KMT2A EP400 E2F6 RFX5 PIAS1 KMT2D BRD7 ZFHX3 YY1AP1 | 7.41e-05 | 203 | 262 | 11 | int:FEV |
| Interaction | NAA40 interactions | TNIK MARS1 RSF1 ZNF318 EDC4 SRCAP PHAX ADAR FASN ZC3H4 KMT2A HELZ CAMSAP2 EXOSC10 EP400 CARMIL1 NUMA1 AAK1 BAZ1B PTPN23 DIDO1 IBTK SETD2 IGBP1 FHOD1 NAT10 CDC5L SON | 7.95e-05 | 978 | 262 | 28 | int:NAA40 |
| Interaction | XRCC6 interactions | ILF2 DNAJA2 ZNF318 PHAX ADAR CACTIN KIF9 TNRC18 ZC3H4 KMT2A THRAP3 MOV10 ARAP1 EXOSC10 EP400 PHRF1 NUMA1 NSD1 NOL11 BAZ1B DIDO1 PIAS1 TFE3 CRY2 NAT10 BRD7 ZFHX3 | 8.21e-05 | 928 | 262 | 27 | int:XRCC6 |
| Interaction | SNRNP40 interactions | BCL9L CENPC RSF1 ZNF318 BCL9 PHAX UBN2 CRNKL1 CACTIN ZC3H4 KMT2A MOV10 EP400 PHRF1 NUMA1 NOL11 SETD2 POLR1E ZFHX3 CDC5L SON | 9.62e-05 | 637 | 262 | 21 | int:SNRNP40 |
| Interaction | YAP1 interactions | BCL9L ILF2 MARS1 SIPA1L3 MPDZ ZNF318 EDC4 SRCAP PHAX UBN2 ADAR WWC2 FASN TNRC18 KMT2A LAMTOR1 THRAP3 MOV10 EXOSC10 NUMA1 NSD1 TRIOBP BAZ1B DIDO1 SETD2 IGBP1 KMT2D NAT10 SMARCA2 NFAT5 | 9.62e-05 | 1095 | 262 | 30 | int:YAP1 |
| Interaction | SUMO2 interactions | CENPC MARS1 EDC4 SRCAP MAST2 FASN HSF2 SEC23B NCAPD3 EXOSC10 EP400 SOBP NUMA1 BAZ1B DIDO1 PIAS1 IGBP1 NAT10 EIF4G1 MORC3 | 9.95e-05 | 591 | 262 | 20 | int:SUMO2 |
| Interaction | H2AZ1 interactions | STK36 RSF1 SRCAP FASN UBE2E1 THRAP3 MEAF6 EP400 NUMA1 NSD1 BAZ1B PIAS1 KANSL1 BRD7 KDM4A | 1.12e-04 | 371 | 262 | 15 | int:H2AZ1 |
| Interaction | CRX interactions | BCL9L BCL9 UBN2 TNRC18 BAHCC1 EP400 E2F6 PIAS1 KMT2D BRD7 SMARCA2 ZFHX3 | 1.30e-04 | 254 | 262 | 12 | int:CRX |
| Interaction | PBRM1 interactions | DNAJA2 FANCA FASN AHR EP400 NUMA1 E2F6 POLR1E BRD7 SMARCA2 KDM4A KDM4B | 1.51e-04 | 258 | 262 | 12 | int:PBRM1 |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P ZNF518B USP17L22 USP17L15 | 1.20e-18 | 79 | 275 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L23 USP17L20 USP17L19 USP17L18 USP17L17 CFAP99 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P ZNF518B USP17L22 USP17L15 | 5.64e-13 | 222 | 275 | 16 | chr4p16 |
| Cytoband | 8p23.1 | 3.50e-04 | 154 | 275 | 6 | 8p23.1 | |
| GeneFamily | PHD finger proteins | 1.45e-06 | 90 | 162 | 8 | 88 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.95e-06 | 11 | 162 | 4 | 1315 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.34e-04 | 34 | 162 | 4 | 487 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 2.38e-04 | 3 | 162 | 2 | 912 | |
| GeneFamily | PDZ domain containing | 4.44e-04 | 152 | 162 | 7 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 6.04e-04 | 160 | 162 | 7 | 555 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.41e-03 | 25 | 162 | 3 | 775 | |
| GeneFamily | Adenosine deaminases acting on RNA | 2.16e-03 | 8 | 162 | 2 | 1303 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.59e-03 | 206 | 162 | 7 | 682 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.76e-03 | 9 | 162 | 2 | 1280 | |
| GeneFamily | Zinc fingers CCCH-type | 3.74e-03 | 35 | 162 | 3 | 73 | |
| GeneFamily | UPF1 like RNA helicases | 4.16e-03 | 11 | 162 | 2 | 1169 | |
| GeneFamily | Zinc fingers CXXC-type | 4.96e-03 | 12 | 162 | 2 | 136 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.38e-17 | 86 | 272 | 17 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.53e-15 | 112 | 272 | 17 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 ABCA1 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 8.12e-14 | 160 | 272 | 18 | MM1155 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP | TNIK DHRS3 RSF1 ZNF318 BCL9 ADAR JARID2 ANKRD12 IKZF2 PTPN23 DGKZ FBXL19 HIVEP3 KDM4A | 1.69e-09 | 162 | 272 | 14 | M8883 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 SRXN1 USP17L21 GLT8D2 USP17L1 CENPC USP17L20 DNAJA2 CCDC18 USP17L19 USP17L18 USP17L17 SYNJ2 USP17L3 USP17L13 NCAPD3 USP17L4 FBXW10 USP17L12 CTDSPL2 USP17L11 NUMA1 USP17L5 ELL3 POLR1E ARHGAP12 USP17L6P PEAK1 LY9 USP17L22 NFAT5 USP17L15 USP17L8 | 2.68e-08 | 1072 | 272 | 33 | MM1031 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPC SEC24A NPIPB3 MAST2 JARID2 UBE2E1 SYNJ2 ZC3H4 TMEM131L HELZ BCAR3 CAMSAP2 NSMAF DOCK1 SASH1 WDR7 BAZ1B FAM171A1 IBTK SETD2 PLPP3 ARHGAP12 SMARCA2 ZFHX3 TMEM131 SON SOS2 | 3.36e-07 | 856 | 272 | 27 | M4500 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ABCA1 DHRS3 PSG1 PSG7 PSG9 SEC24A RSF1 NPIPB3 IRF9 AHR MAP3K9 ANKRD12 HSF2 ABTB2 NSMAF CPT1A IBTK SETD2 ARHGAP12 TTC17 KDM4A MORC3 NFAT5 KDM4B SOS2 | 1.80e-06 | 822 | 272 | 25 | M6782 |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | ZNF318 BCL9 EHBP1L1 ZC3H4 AAK1 NSD1 PIAS1 CELSR1 NAT10 GRIP2 CDC25B | 8.06e-06 | 199 | 272 | 11 | M7254 |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | ZNF318 BCL9 SOBP AAK1 NSD1 RIN1 CELSR1 FHOD1 NAT10 ANKRD11 ZFHX3 | 8.06e-06 | 199 | 272 | 11 | M7259 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.30e-05 | 75 | 272 | 7 | MM605 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 SRXN1 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L5 CPT2 TGFB3 USP17L6P USP17L22 USP17L15 USP17L8 | 1.59e-05 | 647 | 272 | 20 | MM981 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | NPIPB3 ZNF318 GRAMD4 EHBP1L1 POGLUT1 POLR1A DGKZ FBXL19 EIF4G1 KDM4A | 2.41e-05 | 184 | 272 | 10 | M19988 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | SRXN1 NES ABCA1 MARS1 JARID2 ZNF469 PHLDB1 SSH1 SYNJ2 AHR GOLIM4 CAMSAP2 COL12A1 SASH1 LAMA4 ADAM12 TGFB3 FHOD1 ANKRD11 PEAK1 | 3.29e-05 | 681 | 272 | 20 | M39175 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | DHRS3 RSF1 NPIPB3 TUBGCP2 UBN2 PRAG1 KIF9 SYNJ2 IKZF2 SASH1 WDR7 SOBP AAK1 NSD1 LAMA4 PIAS1 SETD2 KANSL1 PLPP3 ZFHX3 KDM4B SORL1 | 4.06e-05 | 807 | 272 | 22 | M16651 |
| Coexpression | BENPORATH_NANOG_TARGETS | BCL9L STK36 ILF2 DHRS3 SEC24A PEX1 MPDZ BCL9 ADAR FANCA JARID2 KIF9 GOLIM4 MOV10 COL12A1 POLR1A SASH1 LAMA4 DIDO1 CPT1A IWS1 WDCP TLE2 NFAT5 SON | 4.10e-05 | 988 | 272 | 25 | M6616 |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | EDC4 ARHGAP31 MAP3K9 THRAP3 CASS4 PHRF1 CPT1A ELL3 CRY2 SETD2 | 4.70e-05 | 199 | 272 | 10 | M9501 |
| Coexpression | GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN | MCM10 FANCA AHR BCAR3 NDST1 NCAPD3 ELL3 POLR1E SMARCA2 GRIP2 | 4.70e-05 | 199 | 272 | 10 | M5983 |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_DN | RSF1 CCDC88B CACTIN KMT2A PTPN23 TGFB3 IL21R ANKRD11 LY9 SORL1 | 4.90e-05 | 200 | 272 | 10 | M4773 |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | STK36 DNAJA2 SIPA1L3 ZC3H4 ANKRD12 FBXL19 PIAS1 IWS1 KDM4A KDM4B | 4.90e-05 | 200 | 272 | 10 | M7532 |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | SEC24A ADAR UNC5A ADAD2 POGLUT1 SSH1 IKZF2 TFE3 HIVEP3 SORL1 | 4.90e-05 | 200 | 272 | 10 | M5068 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 ACP6 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 DNAJA4 AHR USP17L3 TLN2 USP17L13 MEAF6 USP17L4 COL12A1 USP17L12 HTRA2 USP17L11 LAMA4 USP17L5 RLN1 RIN1 USP17L6P TTC17 USP17L22 USP17L15 USP17L8 | 5.65e-05 | 1198 | 272 | 28 | MM1062 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CENPC ZNF318 NPIPB5 JARID2 ZC3H4 AHR TMEM131L HELZ BCAR3 BAZ1B DIDO1 MORC3 | 7.74e-05 | 300 | 272 | 12 | M8702 |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 7.88e-05 | 171 | 272 | 9 | M8820 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CENPC RSF1 CCDC88B ADAR JARID2 SSH1 AHR TMEM131L KMT2A HELZ THRAP3 NSMAF MEAF6 EP400 NUMA1 AAK1 NSD1 BAZ1B RFX5 HIVEP3 SETD2 KMT2D KANSL1 FHOD1 SMARCA2 ANKRD11 GAB3 DDX3Y LY9 NFAT5 SON SORL1 | 8.38e-05 | 1492 | 272 | 32 | M40023 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RSF1 PEX1 CA14 SRCAP PRAG1 PHLDB1 MGAT3 AHR HELZ ANKRD12 CORO7 CAMSAP2 SEC16B IKZF2 SASH1 FHOD3 BCAS1 CPT1A SHROOM2 RFX5 TGFB3 KANSL1 SMARCA2 ZFHX3 SORL1 HR | 9.04e-05 | 1102 | 272 | 26 | M2369 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.17e-04 | 180 | 272 | 9 | M8239 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RSF1 PEX1 CA14 SRCAP PRAG1 PHLDB1 MGAT3 AHR HELZ ANKRD12 CORO7 CAMSAP2 SEC16B IKZF2 SASH1 FHOD3 BCAS1 CPT1A SHROOM2 RFX5 TGFB3 KANSL1 SMARCA2 ZFHX3 SORL1 HR | 1.24e-04 | 1124 | 272 | 26 | MM1070 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | TNIK BCL9L PRAG1 GRAMD4 AHR SLAIN1 ABTB2 IKZF2 CARMIL2 AAK1 DGKZ CELSR1 IL21R GAB3 LY9 CDC25B SORL1 | 8.44e-06 | 405 | 254 | 17 | GSM605796_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_500 | 1.03e-05 | 25 | 254 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | ABCA1 BCL9 CAMSAP2 DOCK1 LAMA4 BAZ1B KANSL1 WDCP MYOCD NFAT5 | 1.28e-05 | 149 | 254 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 |
| CoexpressionAtlas | NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | TNIK ABCA1 DHRS3 PRAG1 GRAMD4 SSH1 NSMAF HDHD5 AAK1 CPT1A SETBP1 GAB3 PEAK1 LY9 SOS2 | 7.76e-05 | 390 | 254 | 15 | GSM538291_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | PEX1 BCL9 UBE2E1 OSBPL6 CAMSAP2 DOCK1 IKZF2 AMN CTDSPL2 NSD1 LAMA4 BAZ1B FHOD3 ELL3 FAM171A1 MLXIPL CELSR1 KANSL1 WDCP MYOCD ZNF518B NFAT5 SORL1 | 9.08e-05 | 795 | 254 | 23 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 9.65e-05 | 89 | 254 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.11e-04 | 91 | 254 | 7 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.21e-04 | 194 | 254 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | CA14 BCL9 GRAMD4 FANCA RPGRIP1 HTRA2 ATP13A1 LAMA4 GRB7 DIDO1 ELL3 MLXIPL CELSR1 ANKRD11 MRPL38 | 1.38e-04 | 411 | 254 | 15 | gudmap_developingKidney_e12.5_renal vesicle_500 |
| CoexpressionAtlas | NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3 | TNIK ABCA1 DHRS3 PRAG1 GRAMD4 SSH1 NSMAF IKZF2 HDHD5 SETBP1 GAB3 PEAK1 LY9 SOS2 | 1.68e-04 | 372 | 254 | 14 | GSM538288_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3 | TNIK BCL9L C2CD4B PRAG1 DNAJA4 ABTB2 CELSR1 IL21R NAT10 GAB3 PEAK1 LY9 SORL1 | 1.79e-04 | 329 | 254 | 13 | GSM538395_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | TNIK BCL9L GRAMD4 AHR ABTB2 IKZF2 CARMIL2 HDHD5 AAK1 DGKZ CELSR1 KMT2D IL21R GAB3 | 2.21e-04 | 382 | 254 | 14 | GSM476684_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | ABCA1 CAMSAP2 DOCK1 LAMA4 BAZ1B ADAM12 KANSL1 WDCP EIF4G1 ZNF518B | 2.21e-04 | 209 | 254 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | ABCA1 BCL9 CAMSAP2 DOCK1 NDST1 LAMA4 BAZ1B IBTK KANSL1 WDCP EIF4G1 MYOCD ZNF518B SON | 2.39e-04 | 385 | 254 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.46e-04 | 173 | 254 | 9 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | BCL9 FANCA ATF7IP2 MAP3K9 CAMSAP2 DOCK1 NCAPD3 IKZF2 CTDSPL2 NSD1 GRB7 BAZ1B DIDO1 FHOD3 ELL3 IBTK CELSR1 KANSL1 WDCP ANKRD11 NFAT5 SORL1 | 2.68e-04 | 801 | 254 | 22 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | TNIK NPIPB4 CENPC ANKRD36C TMEM131L KMT2A ANKRD12 AAK1 KANSL1 DDX3Y SORL1 | 2.48e-08 | 192 | 267 | 11 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CENPC ADAR IRF9 KMT2A HELZ ANKRD12 SETD2 KANSL1 BRD7 ANKRD11 SON | 3.78e-08 | 200 | 267 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MPDZ AHR KMT2A ROBO4 COL12A1 LAMA4 DGKZ FAM171A1 TIE1 ZNF518B SON | 3.78e-08 | 200 | 267 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TNIK SIPA1L3 HUNK ASTN2 PRUNE2 GALNT14 SASH1 BCAS1 CELSR1 NEK11 | 2.16e-07 | 188 | 267 | 10 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | CCDC18 ANKRD36C FANCA KMT2A ANKRD12 AAK1 BAZ1B IHO1 ANKRD11 SON | 2.63e-07 | 192 | 267 | 10 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TNIK NPIPB4 ANKRD36C NPIPB5 IRF9 ANKRD12 IKZF2 AAK1 KANSL1 ANKRD11 | 3.65e-07 | 199 | 267 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.50e-07 | 166 | 267 | 9 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-07 | 169 | 267 | 9 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-07 | 171 | 267 | 9 | 55b194a9bf4d3e4b5d96e0d1298424359c441cbb | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-07 | 171 | 267 | 9 | c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.93e-06 | 186 | 267 | 9 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.93e-06 | 186 | 267 | 9 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | NPIPB4 ANKRD36C TMEM131L KMT2A ANKRD12 KANSL1 ANKRD11 TMEM131 NFAT5 | 2.11e-06 | 188 | 267 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TNIK NPIPB4 ANKRD36C NPIPB5 KMT2A ANKRD12 AAK1 SMARCA2 ANKRD11 | 3.09e-06 | 197 | 267 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-MAIT|ICU-NoSEP / Disease, condition lineage and cell class | 3.50e-06 | 200 | 267 | 9 | 4f03b5f4110ed1637ffe17cb6ff309265a3af9a8 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-MAIT|ICU-NoSEP / Disease, Lineage and Cell Type | 7.44e-06 | 166 | 267 | 8 | d3fa2e42497201f1ca57f4f977fbaa0def950033 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-06 | 168 | 267 | 8 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 173 | 267 | 8 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.19e-05 | 177 | 267 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 178 | 267 | 8 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 179 | 267 | 8 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 180 | 267 | 8 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 180 | 267 | 8 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-05 | 182 | 267 | 8 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Mild-CD4+_T|World / Disease group and Cell class | 1.51e-05 | 183 | 267 | 8 | c4ac8893d38a3da4e19fe2ef1756bd69c89e975c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 184 | 267 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-05 | 133 | 267 | 7 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 186 | 267 | 8 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 186 | 267 | 8 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 186 | 267 | 8 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 188 | 267 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 189 | 267 | 8 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.91e-05 | 189 | 267 | 8 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 191 | 267 | 8 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 191 | 267 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 191 | 267 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-05 | 139 | 267 | 7 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-05 | 192 | 267 | 8 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 192 | 267 | 8 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 192 | 267 | 8 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 192 | 267 | 8 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.22e-05 | 193 | 267 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.22e-05 | 193 | 267 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-05 | 194 | 267 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-05 | 194 | 267 | 8 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 194 | 267 | 8 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 194 | 267 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-05 | 194 | 267 | 8 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 194 | 267 | 8 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.39e-05 | 195 | 267 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.39e-05 | 195 | 267 | 8 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 195 | 267 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.48e-05 | 196 | 267 | 8 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 197 | 267 | 8 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 197 | 267 | 8 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.76e-05 | 199 | 267 | 8 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.22e-05 | 155 | 267 | 7 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 4.40e-05 | 156 | 267 | 7 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.40e-05 | 156 | 267 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.16e-05 | 160 | 267 | 7 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.16e-05 | 160 | 267 | 7 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 110 | 267 | 6 | 438bf761ab0a25e3dc9244c23ae2c2d68a169c7f | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 110 | 267 | 6 | 3639fb5fc02eca509cb220295bc3e6064c23baab | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 110 | 267 | 6 | ff196c71aa2a21cdd812958bd163fa6b91bd2352 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 110 | 267 | 6 | 46635a130453c2fa304f0e09561b2a267c9ceb31 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 162 | 267 | 7 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.58e-05 | 162 | 267 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 162 | 267 | 7 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 162 | 267 | 7 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 164 | 267 | 7 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 164 | 267 | 7 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 164 | 267 | 7 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.27e-05 | 165 | 267 | 7 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.27e-05 | 165 | 267 | 7 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.51e-05 | 166 | 267 | 7 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-05 | 166 | 267 | 7 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.29e-05 | 169 | 267 | 7 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.29e-05 | 169 | 267 | 7 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.85e-05 | 171 | 267 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.44e-05 | 173 | 267 | 7 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.44e-05 | 173 | 267 | 7 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 178 | 267 | 7 | ec6364432d37a32f5152d36d89f5e96dddb72a9d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 179 | 267 | 7 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.04e-04 | 179 | 267 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.12e-04 | 181 | 267 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 182 | 267 | 7 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.16e-04 | 182 | 267 | 7 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.16e-04 | 182 | 267 | 7 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 184 | 267 | 7 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.28e-04 | 185 | 267 | 7 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 186 | 267 | 7 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 186 | 267 | 7 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 186 | 267 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 186 | 267 | 7 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.32e-04 | 186 | 267 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 186 | 267 | 7 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 187 | 267 | 7 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-04 | 187 | 267 | 7 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.37e-04 | 187 | 267 | 7 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 187 | 267 | 7 | aa336fb568a24e12c0454265ddd71ed10a6614cf | |
| Computational | Neighborhood of CDKN1C | 4.00e-05 | 27 | 158 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 9.41e-05 | 32 | 158 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.46e-04 | 35 | 158 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 3.53e-04 | 42 | 158 | 5 | GNF2_MMP11 | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ZNF318 SRCAP CACTIN SYNJ2 BCAR3 ARAP1 SASH1 AAK1 BAZ1B SHROOM2 TGFB3 TLE2 SMARCA2 NEK11 | 5.43e-08 | 196 | 257 | 14 | 1696_DN |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | ABCA1 ATP7B DHRS3 SRCAP MAST2 CACTIN EHBP1L1 SYNJ2 SOBP DIDO1 RLN1 HIVEP3 RIN1 | 2.86e-07 | 191 | 257 | 13 | 3890_DN |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | NES EMC1 SIPA1L3 PEX1 MPDZ SRCAP EP400 NUMA1 BAZ1B BCAS1 CPT2 CDC5L SOS2 | 4.33e-07 | 198 | 257 | 13 | 7016_DN |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | BCL9 PHKB SYNJ2 TLN2 ANKRD12 SASH1 NUMA1 GRB7 RLN1 PLPP3 SMARCA2 SORL1 | 1.30e-06 | 184 | 257 | 12 | 1081_UP |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | MPDZ ZNF318 TUBGCP2 BCL9 MAST2 CHMP7 KMT2A EP400 HTRA2 FHOD1 SMARCA2 KDM4B | 2.26e-06 | 194 | 257 | 12 | 1670_DN |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | EMC1 ATP7B MARS1 MPDZ ZNF318 EHBP1L1 ATF7IP2 ARAP1 NUMA1 PLPP3 ZFHX3 SOS2 | 2.51e-06 | 196 | 257 | 12 | 3272_DN |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | EMC1 EVPL IRF9 CACTIN SYNJ2 ATF7IP2 KMT2A NDST1 SASH1 BAZ1B CPT1A NAT10 | 2.65e-06 | 197 | 257 | 12 | 5292_DN |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; MCF7; HT_HG-U133A | SIPA1L3 CACTIN WWC2 MOCS3 ANKRD12 NUMA1 TRIOBP BAZ1B BCAS1 TGFB3 ZFHX3 SORL1 | 2.79e-06 | 198 | 257 | 12 | 7006_DN |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | EVPL BCL9 MAST2 PHLDB1 SYNJ2 SOBP NUMA1 ADAM12 HIVEP3 RIN1 PLPP3 | 1.02e-05 | 188 | 257 | 11 | 5116_DN |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | EMC1 SIPA1L3 PEX1 EVPL MAST2 GRAMD4 CACTIN MAP3K9 DOCK1 BAZ1B CPT1A | 1.30e-05 | 193 | 257 | 11 | 5440_DN |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | EMC1 ADGRB2 ASTN2 ABTB2 NUMA1 GRB7 BAZ1B CPT1A SETBP1 KDM4A KDM4B | 1.30e-05 | 193 | 257 | 11 | 4488_DN |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A | EMC1 SRCAP CACTIN ATF7IP2 ASTN2 TLN2 DOCK1 GALNT14 ADAM12 HR SOS2 | 1.43e-05 | 195 | 257 | 11 | 6662_DN |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A | EMC1 DHRS3 SIPA1L3 EDC4 SYNJ2 KMT2A CAMSAP2 NDST1 CPT1A CRY2 KDM4B | 1.51e-05 | 196 | 257 | 11 | 2978_DN |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | EMC1 SIPA1L3 MCM10 TUBGCP2 GRAMD4 CACTIN ATF7IP2 DOCK1 NDST1 BAZ1B ADAM12 | 1.58e-05 | 197 | 257 | 11 | 4461_DN |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | EMC1 TUBGCP2 EDC4 WWC2 HSF2 TRIOBP ANKZF1 TLE2 ZFHX3 REEP4 MORC3 | 1.58e-05 | 197 | 257 | 11 | 6941_DN |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | ATP7B PEX1 ZNF318 TUBGCP2 BCL9 SSH1 BAHCC1 DOCK1 HCN4 ADAM12 RLN1 | 1.58e-05 | 197 | 257 | 11 | 5300_UP |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | ZNF318 BCL9 PHKB SYNJ2 ANKRD12 GALNT14 SASH1 EP400 PLPP3 REEP4 MORC3 | 1.66e-05 | 198 | 257 | 11 | 961_DN |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | ZXDC SIPA1L3 EVPL ZNF318 EDC4 BCL9 CACTIN NDST1 DIDO1 CDC5L KDM4B | 1.66e-05 | 198 | 257 | 11 | 3434_DN |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | TNIK SIPA1L3 EVPL SRCAP MOCS3 TLN2 ARAP1 TRIOBP GRB7 ANKZF1 PLPP3 | 1.66e-05 | 198 | 257 | 11 | 5729_DN |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | ZXDC EMC1 SIPA1L3 MPDZ ZNF318 IRF9 CACTIN KMT2A GALNT14 ANKZF1 FHOD1 | 1.73e-05 | 199 | 257 | 11 | 7192_DN |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | EVPL ZNF318 PHKB CACTIN GRB7 BAZ1B ANKZF1 KDM4A CDC5L NFAT5 SOS2 | 1.73e-05 | 199 | 257 | 11 | 7421_DN |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | IRF9 CACTIN PHLDB1 SYNJ2 DOCK1 SASH1 TRIOBP GRB7 DIDO1 CDC5L SOS2 | 1.73e-05 | 199 | 257 | 11 | 7433_DN |
| Drug | chloroacetaldehyde | SRXN1 WWC2 AHR GOLIM4 ASTN2 BCAR3 EP400 WDR7 PPM1D TFE3 GPA33 SON SORL1 | 5.06e-05 | 307 | 257 | 13 | ctd:C004656 |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.62e-05 | 191 | 257 | 10 | 4269_DN | |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | ABCA1 EMC1 SEC24A TUBGCP2 MAST2 SYNJ2 GP1BA EP400 TLE2 ANKRD11 | 7.22e-05 | 193 | 257 | 10 | 544_UP |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A | SIPA1L3 PHLDB1 ASTN2 ARAP1 CASS4 GALNT14 LAMA4 GRB7 TLE2 SOS2 | 7.22e-05 | 193 | 257 | 10 | 6734_DN |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 7.54e-05 | 194 | 257 | 10 | 6832_DN | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 7.54e-05 | 194 | 257 | 10 | 3303_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | SIPA1L3 BCL9 PHKB WWC2 ATF7IP2 DOCK1 SASH1 CARMIL1 CPT2 SOS2 | 7.54e-05 | 194 | 257 | 10 | 5696_DN |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 7.54e-05 | 194 | 257 | 10 | 1264_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | MARS1 SIPA1L3 MAST2 SSH1 BCAS1 SETD2 PLPP3 EIF4G1 KDM4A SOS2 | 7.87e-05 | 195 | 257 | 10 | 3835_DN |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; PC3; HT_HG-U133A | SCN11A MOCS3 ATF7IP2 TMEM131L ARAP1 AAK1 LAMA4 BAZ1B CPT1A ADAM12 | 7.87e-05 | 195 | 257 | 10 | 6635_DN |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | ACP6 SRCAP MAST2 CACTIN CAMSAP2 NUMA1 BAZ1B URGCP PLPP3 KDM4B | 7.87e-05 | 195 | 257 | 10 | 6163_DN |
| Drug | SC 19220; Up 200; 10uM; MCF7; HT_HG-U133A | 7.87e-05 | 195 | 257 | 10 | 7060_UP | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | ZXDC DHRS3 MCM10 FANCA CAMSAP2 NDST1 TGFB3 SETD2 CDC25B SORL1 | 7.87e-05 | 195 | 257 | 10 | 1132_DN |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.87e-05 | 195 | 257 | 10 | 4398_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | GLT8D2 EVPL ECSIT SSH1 KMT2A EP400 TRIOBP ANKZF1 CELSR1 SMARCA2 | 8.21e-05 | 196 | 257 | 10 | 2056_DN |
| Drug | quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A | EMC1 MAST2 FASN POGLUT1 SYNJ2 ANKRD12 SEC23B SASH1 MLXIPL KDM4B | 8.21e-05 | 196 | 257 | 10 | 283_UP |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | TNIK ABCA1 WWC2 POGLUT1 ATF7IP2 EP400 AAK1 ADAM12 HIVEP3 REEP4 | 8.21e-05 | 196 | 257 | 10 | 6295_DN |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | TUBGCP2 SRCAP CACTIN WWC2 SSH1 ATF7IP2 NUMA1 ANKZF1 REEP4 SOS2 | 8.21e-05 | 196 | 257 | 10 | 7017_DN |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 257 | 10 | 5061_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | ABCA1 SRCAP MAST2 CACTIN EHBP1L1 SYNJ2 NDST1 BAZ1B DIDO1 NFAT5 | 8.21e-05 | 196 | 257 | 10 | 2974_DN |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 8.56e-05 | 197 | 257 | 10 | 7335_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; HL60; HG-U133A | MAST2 CACTIN SYNJ2 BAHCC1 NDST1 EXOSC10 SASH1 SMARCA2 CDC5L KDM4B | 8.56e-05 | 197 | 257 | 10 | 1551_DN |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.56e-05 | 197 | 257 | 10 | 3211_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | MPDZ CACTIN SYNJ2 TLN2 ANKRD12 SASH1 NUMA1 BAZ1B NFAT5 KDM4B | 8.56e-05 | 197 | 257 | 10 | 7201_DN |
| Drug | pentamidine isethionate salt; Down 200; 100uM; MCF7; HG-U133A | PSG1 ZNF318 BCL9 PHLDB1 POGLUT1 ATF7IP2 CPT2 ADAM12 HIVEP3 SETBP1 | 8.56e-05 | 197 | 257 | 10 | 639_DN |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | MARS1 SIPA1L3 SSH1 DNAJA4 ARAP1 NUMA1 TRIOBP GRB7 SMARCA2 SOS2 | 8.56e-05 | 197 | 257 | 10 | 1529_DN |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | SIPA1L3 SRCAP CACTIN PHLDB1 EHBP1L1 ASTN2 TLN2 ANKRD12 ARAP1 KDM4B | 8.56e-05 | 197 | 257 | 10 | 1473_DN |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; PC3; HT_HG-U133A | ABCA1 SIPA1L3 SRCAP CACTIN DNAJA4 LAMA4 ADAM12 HIVEP3 ZFHX3 KDM4B | 8.56e-05 | 197 | 257 | 10 | 5803_DN |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; HL60; HG-U133A | SYNJ2 MOCS3 ATF7IP2 ARAP1 BAHCC1 NDST1 DIDO1 RFX5 RIN1 KDM4B | 8.56e-05 | 197 | 257 | 10 | 1608_UP |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 8.56e-05 | 197 | 257 | 10 | 2853_DN | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 8.56e-05 | 197 | 257 | 10 | 3443_DN | |
| Drug | Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | MPDZ EVPL ZNF318 CACTIN SYNJ2 ASTN2 GALNT14 TRIOBP GRB7 KDM4B | 8.93e-05 | 198 | 257 | 10 | 7443_DN |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; HL60; HG-U133A | TUBGCP2 MAST2 AHR SEC23B DIDO1 ANKZF1 RFX5 SETD2 SMARCA2 ANKRD11 | 8.93e-05 | 198 | 257 | 10 | 1415_DN |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; HL60; HT_HG-U133A | 8.93e-05 | 198 | 257 | 10 | 1839_DN | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | ATP7B SIPA1L3 TUBGCP2 EDC4 SRCAP FANCA IRF9 MOCS3 AAK1 SMARCA2 | 8.93e-05 | 198 | 257 | 10 | 5346_UP |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | MARS1 SIPA1L3 TMEM131L GALNT14 AAK1 BAZ1B ANKZF1 RIN1 ZFHX3 NFAT5 | 8.93e-05 | 198 | 257 | 10 | 7126_UP |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | TNIK PHLDB1 MGAT3 ASTN2 TLN2 HSF2 AAK1 LAMA4 SHROOM2 SMARCA2 | 8.93e-05 | 198 | 257 | 10 | 7380_UP |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | PEX1 DNAJA4 ANKRD12 HTRA2 GRB7 BAZ1B CRY2 SMARCA2 NFAT5 NEK11 | 8.93e-05 | 198 | 257 | 10 | 1510_DN |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.93e-05 | 198 | 257 | 10 | 5431_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 8.93e-05 | 198 | 257 | 10 | 4592_DN | |
| Drug | geldanamycin | ZXDC NES UBN2 AHR GOLIM4 KMT2A COL12A1 CTDSPL2 LAMA4 SETD2 SMARCA2 MYOCD NFAT5 SOS2 | 9.01e-05 | 371 | 257 | 14 | ctd:C001277 |
| Drug | Rgd Peptide | PSG1 PSG3 PSG7 MARS1 PSG9 ADGRB1 ADGRB2 GP1BA COL12A1 LAMA4 PLPP3 | 9.19e-05 | 239 | 257 | 11 | CID000104802 |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | EMC1 SIPA1L3 SRCAP MOCS3 BCAR3 ARAP1 BAHCC1 NSD1 HIVEP3 SETD2 | 9.31e-05 | 199 | 257 | 10 | 2683_DN |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HG-U133A | SIPA1L3 SSH1 AHR MAP3K9 SEC23B DOCK1 WDR7 SHROOM2 MORC3 CDC5L | 9.31e-05 | 199 | 257 | 10 | 1889_DN |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; HL60; HG-U133A | 9.31e-05 | 199 | 257 | 10 | 1424_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | SIPA1L3 ZNF318 CACTIN HSF2 ARAP1 DOCK1 NDST1 CRY2 HIVEP3 RIN1 | 9.31e-05 | 199 | 257 | 10 | 4806_DN |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A | CACTIN KMT2A BAHCC1 NDST1 ATP13A1 HIVEP3 SMARCA2 CDC5L KDM4B SON | 9.31e-05 | 199 | 257 | 10 | 1568_DN |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A | 9.31e-05 | 199 | 257 | 10 | 1964_UP | |
| Drug | exemestane; Up 200; 0.01uM; MCF7; HG-U133A | 9.31e-05 | 199 | 257 | 10 | 165_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 9.70e-05 | 200 | 257 | 10 | 988_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; HL60; HG-U133A | 9.70e-05 | 200 | 257 | 10 | 1397_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | SRCAP MAST2 SYNJ2 ATF7IP2 ASTN2 CPT1A ANKZF1 SETD2 WDCP SMARCA2 | 9.70e-05 | 200 | 257 | 10 | 3405_DN |
| Drug | Perhexiline | 1.27e-04 | 2 | 257 | 2 | DB01074 | |
| Drug | Puromycin dihydrochloride [58-58-2]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.60e-04 | 173 | 257 | 9 | 2448_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.91e-04 | 177 | 257 | 9 | 3227_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.91e-04 | 177 | 257 | 9 | 4652_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.99e-04 | 178 | 257 | 9 | 6047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.99e-04 | 178 | 257 | 9 | 5086_DN | |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A | 2.25e-04 | 181 | 257 | 9 | 6048_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; HL60; HG-U133A | 2.65e-04 | 185 | 257 | 9 | 1567_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 2.76e-04 | 186 | 257 | 9 | 6996_UP | |
| Drug | S-(4-bromo-2,3-dioxobutyl)-CoA | 2.90e-04 | 12 | 257 | 3 | CID000188365 | |
| Drug | etomoxiryl-CoA | 2.90e-04 | 12 | 257 | 3 | CID003081714 | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 3.10e-04 | 189 | 257 | 9 | 6831_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 3.10e-04 | 189 | 257 | 9 | 1225_UP | |
| Drug | testosterone enanthate | NES EMC1 MPDZ IRF9 EHBP1L1 GOLIM4 KMT2A ASTN2 CAMSAP2 SEC23B PRUNE2 LAMA4 PLPP3 EIF4G1 DDX3Y NFAT5 SOS2 | 3.11e-04 | 575 | 257 | 17 | ctd:C004648 |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A | 3.35e-04 | 191 | 257 | 9 | 2861_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.35e-04 | 191 | 257 | 9 | 4279_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 3.35e-04 | 191 | 257 | 9 | 1706_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.48e-04 | 192 | 257 | 9 | 6808_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.48e-04 | 192 | 257 | 9 | 849_DN | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.48e-04 | 192 | 257 | 9 | 1517_DN | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A | 3.48e-04 | 192 | 257 | 9 | 1623_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; HL60; HT_HG-U133A | 3.62e-04 | 193 | 257 | 9 | 2996_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.62e-04 | 193 | 257 | 9 | 5726_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.62e-04 | 193 | 257 | 9 | 3906_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.76e-04 | 194 | 257 | 9 | 7410_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.76e-04 | 194 | 257 | 9 | 6833_DN | |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 KMT2A USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 KMT2D USP17L6P USP17L22 USP17L15 USP17L8 SON | 7.94e-27 | 69 | 264 | 21 | DOID:1682 (implicated_via_orthology) |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.69e-25 | 46 | 264 | 18 | DOID:5426 (implicated_via_orthology) |
| Disease | Neurodevelopmental Disorders | 1.60e-07 | 93 | 264 | 9 | C1535926 | |
| Disease | hyperuricemia | 1.07e-05 | 33 | 264 | 5 | EFO_0009104 | |
| Disease | hearing loss | 3.06e-05 | 67 | 264 | 6 | EFO_0004238 | |
| Disease | Adenoid Cystic Carcinoma | 3.34e-05 | 100 | 264 | 7 | C0010606 | |
| Disease | Malignant neoplasm of breast | ATP7B ZNF318 ADAR PHKB FASN SYNJ2 AHR GOLIM4 ASTN2 LRRC7 BCAR3 KIF6 PPM1D GRB7 CPT1A SHROOM2 ADAM12 SETD2 IGBP1 KMT2D WDCP SETBP1 RNF182 SORL1 | 4.04e-05 | 1074 | 264 | 24 | C0006142 |
| Disease | uric acid measurement | TNIK ABCA1 SIPA1L3 CCDC18 ZNF318 FANCA POLR1A CARMIL1 AAK1 BAZ1B BCAS1 MLXIPL SETBP1 ZNF518B NFAT5 KDM4B SOS2 | 4.05e-05 | 610 | 264 | 17 | EFO_0004761 |
| Disease | intraocular pressure measurement | GLT8D2 ABCA1 ADGRB2 FANCA ZNF469 EFHC1 SYNJ2 KMT2A EXOSC10 TRIOBP ADAM12 HIVEP3 ZFHX3 CDC5L SOS2 | 6.19e-05 | 509 | 264 | 15 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLQPPSILEIRTKNF | 271 | P35869 | |
| TLGSLPPKPRERLTL | 1551 | O60241 | |
| DKPLPPIQVASLRAE | 2506 | Q96L91 | |
| PVPTLLAQPEALRSK | 2396 | Q9P281 | |
| KPRLAASLQISPQPR | 16 | Q8NCV1 | |
| LRPLNVEPPLTDLQK | 556 | Q99459 | |
| LEEKRFRTLPLVPSP | 226 | Q9HB65 | |
| LQAKPSPSPRAELLV | 1886 | Q6UB99 | |
| PNLPLLPTRNLSTVK | 91 | O15467 | |
| EVQEPEKRPLTPSLS | 1461 | A6NC98 | |
| PLTEEQLNRKPALPL | 266 | Q05D32 | |
| PKQAILTLPRPVRAS | 151 | Q9NQ75 | |
| TATELLKSELLPPPQ | 991 | Q9P2K8 | |
| ILPIQPALTPRKRAT | 381 | Q2M2I8 | |
| VRLDLPPEKPLTSSL | 111 | Q9NPI1 | |
| QILTALSRKLEPPPV | 806 | O75815 | |
| KELEPLQPSPLELRS | 1546 | O14514 | |
| PIDIERLQSTNPKRP | 221 | P35670 | |
| VPADSLIRTERPPNK | 236 | Q9UIG0 | |
| PAERPLRLQRSPVLK | 1371 | Q6F5E8 | |
| ASQVPAEPKERPLLS | 576 | P51816 | |
| PLKTLSRERPLPNIF | 1036 | Q9HD20 | |
| IPLKVPRTSPRDSEE | 36 | Q6IC98 | |
| RLSNPPIDVKRTSIP | 871 | Q5XX13 | |
| IRPRPVNAKLSPLND | 1876 | O95477 | |
| PSLSPSGKRLPRILE | 51 | A8MU93 | |
| LPRLPVPAVKDTVNR | 171 | P50416 | |
| KPLPADPLARTTRLT | 856 | O43184 | |
| SEELPLPRRLSLVPK | 416 | Q9BXJ7 | |
| SLEKLPQLEALLPPR | 336 | Q8WW22 | |
| PPPLTLTEQTLKGRL | 2936 | Q9NYQ6 | |
| QILPSKTPLPSALDE | 346 | Q6UB98 | |
| RRPGKEQLSPTPVLL | 991 | O75129 | |
| PRDQRPPRLSEIKIS | 56 | Q9H0I3 | |
| QDSLPRLPIPKLEDT | 46 | P23786 | |
| KDSQLRELLLPPPDT | 546 | Q6PCT2 | |
| SSSPVDLPLRPRKQA | 31 | Q86UQ8 | |
| LKTPSERQLTALPPS | 511 | Q92617 | |
| DNLKTPSERQLTPLP | 881 | Q92617 | |
| RPLERTDSRPQPLDK | 2281 | Q96L73 | |
| PERLAQPPKDLEART | 281 | P48382 | |
| LTRPPEELTLSPKLQ | 646 | Q6P2E9 | |
| SPLPDRSLPALKIRE | 621 | Q96ST2 | |
| TAPKPLLPRREESEA | 721 | Q9H3S7 | |
| EKLSPSLRLLNPSRP | 231 | P0C860 | |
| LIPIRPADPEKNQSL | 231 | Q9H8H0 | |
| RKIISPRSIEDVLPP | 411 | Q5JPF3 | |
| EPKEFNLTAPRPRTI | 186 | D6REC4 | |
| PERDPLILLSRKNPK | 216 | Q8NBL1 | |
| PAPSSPEKEQLLDRR | 521 | Q5VUB5 | |
| IPPPDKRRNSELFQT | 401 | Q6ZWB6 | |
| EPLPPKRLLNLTLEV | 721 | Q14667 | |
| KIEPTDRPPILLIAN | 196 | Q9NZR2 | |
| SRVRLLVLVPPSKPE | 131 | Q99795 | |
| SNLPTKERLVPREVP | 191 | Q09327 | |
| LRESPAQAPKISDLP | 1881 | Q6PRD1 | |
| PQPLDSKPLLSQREA | 731 | Q96NW7 | |
| LKISAPQPIPSNRID | 1086 | Q9P2D0 | |
| PSVLAELKRLISVPP | 251 | Q8IYA8 | |
| RKSRPPPLDLRNLSI | 446 | Q8WWW8 | |
| TLVAESLKQTLPPPL | 1521 | Q5HYC2 | |
| PLSSRAPLPERLEAK | 226 | A6NLJ0 | |
| ELRKPGRLPDTALPT | 526 | P57737 | |
| PSIPRLAKEPLAAAE | 211 | O43593 | |
| NSSRQERPPVKPFIL | 231 | P78318 | |
| PPQSEPESNSLKRRL | 531 | Q14149 | |
| LEPSPLRQAKPIADL | 36 | Q8N119 | |
| PLRKERPVPSAANSI | 1221 | Q9H792 | |
| SLEPTLAVSAPKRPR | 831 | Q92817 | |
| ARVPQPDPSRELKTL | 206 | Q8N3D4 | |
| NPSLRPSAIEILKIP | 271 | Q8NG66 | |
| PLKPAPRRTDISELP | 666 | Q9P1Y6 | |
| PRRTDISELPRIPKI | 671 | Q9P1Y6 | |
| RLLPLKPVQAATPSR | 66 | P52848 | |
| TLRPPEKVDLEPLKS | 776 | P48681 | |
| LEDSIPKRPVSSIPL | 771 | Q6ZMV9 | |
| ERVTAPKAERLLNPP | 761 | Q7Z3B3 | |
| AERSPVDVSKIPLPR | 811 | O75164 | |
| LPSKSRQKTRPLIPE | 716 | O94953 | |
| PILKRLERPQDRDTP | 331 | P30305 | |
| LKTPSERQLTALPPS | 511 | A8MRT5 | |
| KPVEDITPPRLEALL | 541 | Q9BSJ2 | |
| KIRPDSSRPELLQPL | 121 | Q9H1C3 | |
| LTLRRKATEPPPSQE | 601 | O75022 | |
| LPAPAPRREKTNEEL | 101 | Q7L590 | |
| PLPSDSPKEELRPIR | 556 | Q9HAQ2 | |
| EEKPSPRRSLSQPLP | 36 | O15297 | |
| SPETRLDSLPPVIKF | 81 | Q8NFH4 | |
| SLREVLENVPASPKP | 456 | Q8WWR8 | |
| DNLKTPSERQLTPLP | 551 | C9JG80 | |
| SSRTAQPRELIAPPK | 1821 | P42694 | |
| LIRPKSRPQEREASP | 386 | Q9UKS7 | |
| LPKELQLPPSRETSV | 31 | O94916 | |
| VSRQLLEPEPVPLSK | 51 | Q9BZF3 | |
| PEEVKRSQPLLIPTT | 36 | Q14451 | |
| TPPLTPGRLTQDLKL | 1071 | Q9Y3Q4 | |
| PLPPNLDDLKVSELR | 366 | Q8IZQ8 | |
| LEEVITPRKDLPPLL | 681 | Q9H0A0 | |
| KRPRLLPEPANTDTR | 301 | D6RGH6 | |
| LQELKISQSALPPLP | 246 | Q8IWW6 | |
| SPEQKARRLDPTEPI | 261 | Q96FL9 | |
| LNRIPSLRKPDPAEQ | 241 | O00461 | |
| DNLKTPSERQLTPLP | 471 | E5RHQ5 | |
| DNLKTPSERQLTPLP | 1021 | E5RHQ5 | |
| KPIIPNLLPQSTGRE | 766 | Q9Y5E2 | |
| LEDLLPSRPEVPNII | 351 | O60884 | |
| PLPQALSKERRERPQ | 211 | Q01780 | |
| RELELLPPPPQQKIT | 201 | Q9BZJ0 | |
| TLRIQTKEPLPTLPL | 231 | O43464 | |
| PDLPTLSRIEILAPQ | 1201 | B1AJZ9 | |
| VRQLPELNPKLTGSP | 1691 | Q86XA9 | |
| PARKLPSLLLDPTEE | 6 | O75461 | |
| ETISPLRPQRPKSQV | 1731 | Q14185 | |
| LLSRSPEAQPKTLPL | 821 | P55265 | |
| KRARVAELPTPELPS | 576 | Q49AN0 | |
| EVTLPLPRPQDLKLR | 1561 | Q99715 | |
| KLQLAPSPADPRVLS | 511 | Q9H8Y5 | |
| PNPSRSEKLILDVQP | 56 | Q5T9S5 | |
| PLQPTRVKDPETREI | 821 | Q03188 | |
| TTKEPLDLPDNPRNR | 391 | Q8WUX9 | |
| PLDTSKLSTDQRLPP | 471 | Q53ET0 | |
| ALLTPRVLPKVPDSR | 586 | O15360 | |
| IPEFDLSRIIPSEKP | 1231 | O00512 | |
| LPPPRTIKIAILNFD | 976 | Q2V2M9 | |
| SKPASTVREAPRPLI | 151 | Q86WZ0 | |
| LITTVPPNLRKLDPE | 176 | Q12905 | |
| FLRSLLEPDPVKRPN | 296 | P57058 | |
| IPEFDLSRIIPSEKP | 1321 | Q86UU0 | |
| LIPLSAQDPVPSKLL | 1161 | Q9BTC0 | |
| KTPLRPLDPTRLQGI | 646 | Q04637 | |
| APLPELVDKTRDTLP | 561 | Q5U623 | |
| RNLTALPPDLPKDTT | 36 | P07359 | |
| EKLDTPLRPARQQPT | 516 | Q9HBG7 | |
| LLEERRTPPPTKRSL | 861 | Q6P0Q8 | |
| REERKLLLDPSSPPT | 16 | Q6IAA8 | |
| KAAPPQIPDTRRELA | 6 | Q9HAF1 | |
| ITDLPRIDVSKREPP | 361 | Q5JVL4 | |
| KPGPLEPTQRLLSQL | 261 | Q00978 | |
| EPDSISQPIIKIPLR | 66 | Q92636 | |
| PPIKIARLESTPNSR | 436 | Q03164 | |
| PILKQEPQSPSRSLE | 481 | Q8WUQ7 | |
| PSLESKLPLPNSRIR | 431 | A6NN90 | |
| VIPQKPRTASRPDDI | 1271 | Q5VZK9 | |
| PPRSPAKRLQLTELQ | 321 | Q9HBE5 | |
| LSLPKALLDPRRPEI | 871 | Q8N766 | |
| LSTLDQLRLKPPPPV | 361 | Q13574 | |
| RAQRSLAPEPKEPLI | 506 | Q9Y613 | |
| KPLPPSERLEQELFS | 136 | O15523 | |
| LSQLTEPPKLLPQID | 46 | P42261 | |
| VPQSQRPLRPSEAVK | 331 | Q9C0E4 | |
| VLAQERPKLPEDPLL | 1201 | P49327 | |
| DKVLSAARDPTLLPP | 161 | O75363 | |
| ESPSLAIRSPTLRKP | 16 | A0A1B0GTI1 | |
| TSVPPFNLRELLPKQ | 191 | Q9ULX7 | |
| QRLSPIPEEVPKSTL | 601 | Q96T23 | |
| IPRSLKLQPRENLPK | 441 | O43933 | |
| PNELKITPLNRTLTP | 991 | Q08AD1 | |
| PVLPEKLIRQEALPL | 1106 | Q9C0B2 | |
| PRQRPTKALVPFEDL | 61 | Q9BQ95 | |
| STLERPKTLEFLPRP | 981 | P80192 | |
| VSPLPPKAALSRDEI | 46 | O95396 | |
| PIPLPSAAELLVKRE | 136 | Q9Y5R6 | |
| NLFPPLKPETVARRT | 236 | O75911 | |
| SRSDPVTLNLLPKLP | 226 | P11464 | |
| PLKSINLPRPDNETL | 31 | Q93100 | |
| DNLKTPSERQLTPLP | 551 | A6NJU9 | |
| LRRPLPPSADDNLKT | 791 | A6NJU9 | |
| DNLKTPSERQLTPLP | 801 | A6NJU9 | |
| ASPISQRLPPKVESL | 1756 | Q14980 | |
| LASPRPDRALVQLPK | 126 | Q53GL7 | |
| PDRALVQLPKPLSEA | 131 | Q53GL7 | |
| TVAPSDRPLQLPKVL | 21 | Q9H814 | |
| SRSDPVTLNLLPKLP | 226 | Q16557 | |
| PARPREKPLIRSQSL | 211 | Q9H6H4 | |
| PVALKLPERNTPRNS | 1441 | Q16363 | |
| LDPEPTQSKLVRLEP | 491 | Q03933 | |
| LLPPPATQISDLSKR | 136 | Q92833 | |
| LPLPPAQTSDRLAKR | 401 | Q9GZS1 | |
| KDVSRRPLVPVLSPQ | 121 | Q9BSD3 | |
| PLRRKRSAALQPEPI | 76 | Q92673 | |
| PVLPQLKARSPQELD | 201 | Q13671 | |
| RLPRSPPLKVLAEQL | 16 | Q96E14 | |
| LPLSETETPVSLRKP | 1151 | Q96KN7 | |
| EEDPSLPALLTQPRK | 1471 | O95602 | |
| LLKEENEQPLRLPSP | 556 | Q07890 | |
| ILSILEEKFPNLPPR | 191 | Q8WUY3 | |
| LENLPGSLPPDLRTK | 361 | P51531 | |
| LPTQLPSPEELRRKI | 416 | Q9BRC7 | |
| PEPPNLSRNKETELL | 161 | Q8NHS9 | |
| APVSRPPEQSDLKLV | 1226 | A2VDJ0 | |
| PTLRRTGKPLSPEEQ | 1241 | O15056 | |
| VAPRDVPLLPSDVKL | 476 | Q9HCE1 | |
| LPAPAIRKEILSPVD | 286 | O14495 | |
| PELKAALSERQPSLP | 96 | P04808 | |
| PQPPILQLSVEKLSR | 966 | O95486 | |
| SRSDPVTLNLLPKLP | 226 | Q00887 | |
| LKTTPLPRNDFPRIE | 176 | Q9BXW7 | |
| PEFNSLPRKLLQPER | 336 | Q96QH2 | |
| LQPPKPLSSLSTLRD | 546 | Q8ND83 | |
| SRPLKQTPIVPFRES | 1111 | O60292 | |
| LRPKRSPPVISEEAA | 51 | Q6ZNX1 | |
| KLLPKIPSPRSTEER | 1366 | Q13796 | |
| LPENPTELLLTPKRL | 101 | Q8N6D2 | |
| VEPKRPSRPINITSL | 241 | O75925 | |
| SRSDPVTLNLLPKLP | 226 | Q13046 | |
| RLRPGSLVPPLETEK | 3121 | Q6ZRS2 | |
| TLAPSRPLLVPKAER | 586 | Q9NP71 | |
| ELPRELGKRSPLTSP | 1501 | Q9H2D6 | |
| LLTPLKERPDLPPVQ | 41 | Q15437 | |
| TPFTSRLPPELQVLK | 271 | Q9NRP7 | |
| EPAVLLTPPRQKSNL | 531 | Q8N0Z3 | |
| NVLLLRLPEKVPSAP | 336 | Q8WZ75 | |
| LEPSRETPKVLPKSL | 741 | Q8WYL5 | |
| PSIPEIRKTLPARLD | 821 | Q8N961 | |
| RTGPPRLLVSLPTKE | 161 | Q96P48 | |
| TPETGPLQRLLPKAR | 1331 | P42695 | |
| ELQRTLPSVPPDTKL | 71 | Q7RTU0 | |
| LSPEDKPIRLSPSKI | 1126 | O15417 | |
| PVVDPLKNLRLPREL | 1436 | O15417 | |
| RLRQPPETLLTLRPK | 581 | Q8TCY9 | |
| APVARQLAPREKLPL | 56 | A6NCW0 | |
| QLAPREKLPLSSRRP | 61 | A6NCW0 | |
| NPPLPTRIEKFDRSS | 646 | Q9UKE5 | |
| ELSPRERSPALKSPL | 241 | Q9Y2W1 | |
| SIQNPKVSLEPLPAR | 861 | Q6ZU65 | |
| PRENASVPELLAPIK | 646 | Q2QGD7 | |
| RSQPPTRIPTLVDKE | 951 | Q6AWC2 | |
| APVARQLAPREKLPL | 56 | A6NCW7 | |
| QLAPREKLPLSSRRP | 61 | A6NCW7 | |
| GLPPPKVSRTQQLLE | 91 | Q96DV4 | |
| PSVNSPLLRSPIQRK | 221 | P18577 | |
| SIINRPRKSPLPSLL | 1241 | O75970 | |
| ELKSQPLPLRSSLPI | 66 | P19532 | |
| NIPLTDARRKAPSPV | 301 | A7XYQ1 | |
| LTLTRRPKLQPEPLS | 816 | P35590 | |
| RPLPSVLDPAKVQSL | 51 | Q9BYN0 | |
| PPLESKQRRNLPSKI | 1491 | Q92545 | |
| APVARQLAPREKLPL | 56 | D6R9N7 | |
| QLAPREKLPLSSRRP | 61 | D6R9N7 | |
| EDKPSLVPLSVPRTQ | 446 | Q5T1R4 | |
| APVARQLAPREKLPL | 56 | A8MUK1 | |
| QLAPREKLPLSSRRP | 61 | A8MUK1 | |
| PLTPKSILRLPETEL | 16 | Q96S82 | |
| APVARQLAPREKLPL | 56 | D6R901 | |
| VPEARQLAPREKLPL | 56 | C9JLJ4 | |
| QLAPREKLPLSSRRP | 61 | C9JLJ4 | |
| RPPQPKSVEDLLDRI | 631 | O94885 | |
| APVARQLAPREKLPL | 56 | D6RCP7 | |
| QLAPREKLPLSSRRP | 61 | D6RCP7 | |
| ARSPLKPLPLEEQVE | 61 | Q9NPH0 | |
| KNRPSSLNLDPAIPI | 1101 | Q2M1Z3 | |
| SRLQKILAESPPPAR | 246 | Q6ZMU5 | |
| APVARQLAPREKLPL | 56 | Q7RTZ2 | |
| QLAPREKLPLSSRRP | 61 | Q7RTZ2 | |
| PLPTRTTPDPKLNRE | 471 | Q86UU1 | |
| ERVNLSAPLLPKEDP | 181 | Q96AE7 | |
| PEGPREKQLPRLIIS | 1201 | Q86YV5 | |
| PTVRSILELSPQPKN | 306 | A8MZF0 | |
| PSLENFLRKRPIVPE | 341 | Q5HYM0 | |
| RSLKEPPIIIVPESL | 236 | Q9BYW2 | |
| EVISKPQTPLAARPR | 851 | Q96JE7 | |
| PFLIRQKIISSLDPP | 756 | Q6ZN44 | |
| ALREKAVNIPLDPLP | 931 | Q9UPT8 | |
| LTKILPERPPSAQDG | 376 | Q96JG9 | |
| LEPKLEPQELSPLSA | 701 | Q9H869 | |
| APVARQLAPREKLPL | 56 | C9JPN9 | |
| APVARQLAPREKLPL | 56 | Q0WX57 | |
| QLAPREKLPLSSRRP | 61 | Q0WX57 | |
| IRTARSLAINPKDPP | 1616 | Q9Y4G6 | |
| APVARQLAPREKLPL | 56 | P0C7H9 | |
| QLAPREKLPLSSRRP | 61 | P0C7H9 | |
| APVARQLAPREKLPL | 56 | P0C7I0 | |
| QLAPREKLPLSSRRP | 61 | P0C7I0 | |
| EVPQPRPQLDLKASR | 46 | Q9UI33 | |
| TPEQPVLDLKRPFLS | 46 | P0C7P4 | |
| LPSLDEQVIPARLPK | 96 | Q5PR19 | |
| APVARQLAPREKLPL | 56 | Q6QN14 | |
| QLAPREKLPLSSRRP | 61 | Q6QN14 | |
| PDSPQEPLVLRLKFL | 96 | Q9BVT8 | |
| TLEPPRLPQRKNLQS | 536 | Q9H6R7 | |
| RIQKELADITLDPPP | 51 | P51965 | |
| APVARQLAPREKLPL | 56 | D6RA61 | |
| QLAPREKLPLSSRRP | 61 | D6RA61 | |
| RITIPIKAPSLDPTN | 401 | Q9Y6X0 | |
| SPLPRAKELILNDLP | 281 | Q04725 | |
| APVARQLAPREKLPL | 56 | C9J2P7 | |
| QLAPREKLPLSSRRP | 61 | C9J2P7 | |
| APVARQLAPREKLPL | 56 | D6RBQ6 | |
| QLAPREKLPLSSRRP | 61 | D6RBQ6 | |
| IEPPKLLTRPRSSSQ | 1141 | Q9Y4E6 | |
| EITPPALFRQPSKRI | 256 | P0DJG4 | |
| SRPNLRVIPTVTPDK | 831 | Q5VUA4 | |
| TKIRPNLPIPSTVLR | 1346 | Q5VUA4 | |
| PFLTRPKVPVLQLDS | 41 | P56192 | |
| TRPQELPELPKTTAL | 356 | P18583 | |
| QILSKLRLTSPPEPT | 46 | P10600 | |
| APVARQLAPREKLPL | 56 | D6RBM5 | |
| QLAPREKLPLSSRRP | 61 | D6RBM5 | |
| APVARQLAPREKLPL | 56 | D6RJB6 | |
| QLAPREKLPLSSRRP | 61 | D6RJB6 | |
| NTPREVSPLLPKLPE | 3426 | Q15911 | |
| APVARQLAPREKLPL | 56 | C9JVI0 | |
| QLAPREKLPLSSRRP | 61 | C9JVI0 | |
| SPNIETPLRPKLRKE | 836 | Q9C0D4 | |
| KGSPLNSPLDRLPLV | 666 | Q5R3F8 | |
| ASEPRLASVLPEVKP | 3106 | O14686 | |
| ISSDQVRLLPPPKNE | 151 | Q6P5S2 |